https://curecurrent.com/trials/fasudil-trial-for-treatment-of-early-alzheimer-s-disease-fead-62002https://curecurrent.com/trials/latam-fingers-initiative-for-cognitive-change-62003https://curecurrent.com/trials/developing-an-artificial-intelligence-system-to-detect-cognitive-impairment-62004https://curecurrent.com/trials/a-study-testing-whether-low-dose-radiation-could-help-the-immune-system-and-possibly-improve-early-onset-alzheimer-s-dis-62005https://curecurrent.com/trials/phenserine-on-the-alzheimer-s-treatment-horizon-study-1-62006https://curecurrent.com/trials/exercise-for-brain-health-in-the-fight-against-alzheimer-s-disease-62007https://curecurrent.com/trials/promoting-independence-with-compensatory-cognitive-rehabilitation-62008https://curecurrent.com/trials/phase-ii-trial-to-evaluate-safety-and-efficacy-of-gm-csf-sargramostim-in-alzheimer-s-disease-62009https://curecurrent.com/trials/a-phase-ia-ib-first-in-human-fih-study-for-safety-tolerability-pharmacokinetics-pk-and-clinical-activity-evaluation-of-a-62010https://curecurrent.com/trials/characterizing-variability-in-hearing-aid-outcomes-in-among-older-adults-with-alzheimer-s-dementia-62011https://curecurrent.com/trials/development-standardisation-and-standardisation-project-for-a-new-memory-assessment-62012https://curecurrent.com/trials/social-affective-cognition-in-alzheimer-s-disease-associated-disorders-62013https://curecurrent.com/trials/telemedicine-self-examination-of-speech-and-memory-for-rapid-detection-of-cognitive-impairments-using-machine-learning-m-62014https://curecurrent.com/trials/inspiring-seniors-towards-exercise-promotion-to-protect-cognition-62015https://curecurrent.com/trials/elpipodect-mk-8189-safety-and-tolerability-in-participants-with-alzheimer-s-disease-with-or-without-symptoms-of-agitatio-62016https://curecurrent.com/trials/aerobic-exercise-for-older-adults-at-increased-risk-of-alzheimer-s-disease-and-related-dementias-62017https://curecurrent.com/trials/studies-of-brain-and-body-interaction-62018https://curecurrent.com/trials/minnesota-inclusive-ltss-for-lgbtq-seniors-62019https://curecurrent.com/trials/an-objective-assessment-tool-for-evaluating-functioning-in-older-adults-62020https://curecurrent.com/trials/feasibility-of-a-systems-approach-for-alzheimer-s-services-among-latinos-attending-primary-care-practices-62021https://curecurrent.com/trials/learning-skills-together-family-caregiver-complex-intervention-62022https://curecurrent.com/trials/genetic-studies-of-early-onset-dementia-62023https://curecurrent.com/trials/palliative-care-education-in-assisted-living-for-dementia-care-providers-pceal-dcp-62024https://curecurrent.com/trials/effect-of-low-dose-radiotherapy-on-brain-amyloidosis-in-the-treatment-of-alzheimer-s-disease-62025https://curecurrent.com/trials/decision-making-tool-for-firearm-storage-62026https://curecurrent.com/trials/promoting-positive-care-interactions-ppci-in-assisted-living-62027https://curecurrent.com/trials/individualized-brain-stimulation-to-improve-mobility-in-alzheimer-s-disease-62028https://curecurrent.com/trials/efficacy-and-safety-of-temporal-interference-stimulation-on-cognitive-function-in-patients-with-early-stage-alzheimer-s-62029https://curecurrent.com/trials/prospective-observational-study-of-the-relationship-between-sociodemographic-factors-blood-based-biomarkers-and-psychiat-62030https://curecurrent.com/trials/detecting-beta-amyloid-in-the-retina-62031https://curecurrent.com/trials/the-brain-senses-study-62032https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-atnc-mdd-v1-tms-with-cognitive-training-in-mild-alzheimer-s-dementia-62033https://curecurrent.com/trials/effect-of-scene-based-training-on-cognitive-function-in-patients-with-alzheimer-s-disease-62034https://curecurrent.com/trials/long-term-effect-of-brain-stimulation-in-ppa-62035https://curecurrent.com/trials/a-medium-chain-triglyceride-intervention-for-patients-with-alzheimer-disease-62036https://curecurrent.com/trials/virtual-communication-in-the-hospital-impact-on-patients-and-surrogates-62037https://curecurrent.com/trials/a-multifocal-tdcs-eeg-protocol-for-improving-symptoms-of-mild-cognitive-impairment-and-early-dementia-62038https://curecurrent.com/trials/retinal-hyperspectral-imaging-in-neurodegenerative-diseases-62039https://curecurrent.com/trials/alzheimer-s-disease-and-faecal-microbiota-transplantation-a-pilot-study-62040https://curecurrent.com/trials/choline-effects-pre-symptomatic-ad-62041https://curecurrent.com/trials/amyloid-monoclonal-antibody-treatment-in-pd-patients-with-coexistent-ad-pathology-62042https://curecurrent.com/trials/a-postmarketing-study-of-leqembi-in-south-korean-participants-with-alzheimer-s-disease-62043https://curecurrent.com/trials/music-effects-on-dementia-62044https://curecurrent.com/trials/the-nightlight-falls-prevention-study-62045https://curecurrent.com/trials/large-language-model-for-understanding-and-monitoring-elderly-neurocognition-62046https://curecurrent.com/trials/stem-cell-therapy-for-early-alzheimer-s-disease-62047https://curecurrent.com/trials/effect-of-caffeine-on-cognition-in-alzheimer-s-disease-62048https://curecurrent.com/trials/genetics-of-mendelian-forms-of-young-onset-alzheimer-disease-62049https://curecurrent.com/trials/a-study-to-assess-safety-and-tolerability-and-to-explore-efficacy-of-nsc001-in-mild-to-moderate-alzheimer-s-disease-62050https://curecurrent.com/trials/decision-making-and-implementation-of-aging-in-place-long-term-care-plans-among-older-adults-62051https://curecurrent.com/trials/feasibility-of-improving-glycemia-with-heat-therapy-to-prevent-ad-62052https://curecurrent.com/trials/improving-dementia-care-in-primary-practice-62053https://curecurrent.com/trials/decision-making-ethical-consent-and-interactive-dialogue-in-ongoing-neurocognitive-decline-decision-62054https://curecurrent.com/trials/biomarker-predictors-of-memantine-sensitivity-in-patients-with-alzheimer-s-disease-62055https://curecurrent.com/trials/safety-and-efficacy-of-plasma-transfusion-from-exercise-trained-donors-in-patients-with-early-alzheimer-s-disease-62056https://curecurrent.com/trials/links-between-self-awareness-and-sociocognitive-processes-in-neurodegenerative-diseases-62057https://curecurrent.com/trials/development-of-a-database-to-investigate-digital-and-blood-based-biomarkers-and-their-relationship-to-tau-and-amyloid-pe-62058https://curecurrent.com/trials/neuroinflammation-imaging-in-ad-62059https://curecurrent.com/trials/acoustic-stimulation-during-sleep-effects-on-memory-and-p-tau217-in-mci-62060https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-study-of-povorcitinib-in-participants-with-prurigo-nodularis-stop-pn2-62061https://curecurrent.com/trials/cognitive-neurology-unit-clinical-registry-62062https://curecurrent.com/trials/targeting-brain-physiology-to-treat-neuropsychiatric-symptoms-of-dementia-using-tms-eeg-and-tdcs-62063https://curecurrent.com/trials/prevalence-and-level-of-diagnosis-of-dementia-in-a-population-based-sample-in-the-county-of-tr-ndelag-62064https://curecurrent.com/trials/home-based-cr-and-tdcs-to-enhance-cognition-in-persons-with-mild-cognitive-impairment-and-late-life-depression-62065https://curecurrent.com/trials/ultralow-dose-pet-imaging-of-18f-florbetapir-18f-flutemetamol-62066https://curecurrent.com/trials/standardizing-care-for-neuropsychiatric-symptoms-and-quality-of-life-in-dementia-62067https://curecurrent.com/trials/transcranial-near-infrared-light-therapy-for-mild-moderate-alzheimer-s-disease-nir4ad-62068https://curecurrent.com/trials/links-between-cognitive-deficits-during-normal-or-pathological-aging-and-slow-waves-measured-in-eeg-62069https://curecurrent.com/trials/tacs-to-engage-theta-gamma-coupling-and-enhance-working-memory-in-patients-with-mci-tacs-mci-62070https://curecurrent.com/trials/div-ad-barcelona-alzheimer-s-blood-based-biomakers-for-a-diverse-community-62071https://curecurrent.com/trials/rtms-for-apathy-clinical-trial-62072https://curecurrent.com/trials/a-phase-2-randomized-prospective-double-blind-single-center-placebo-controlled-study-to-evaluate-safety-tolerability-tar-62073https://curecurrent.com/trials/real-world-outcomes-of-intranasal-muse-exosomes-and-stem-cells-in-neurological-regenerative-therapy-62074https://curecurrent.com/trials/prevention-of-alzheimer-s-disease-with-cr-plus-tdcs-in-mild-cognitive-impairment-and-depression-pact-md-62075https://curecurrent.com/trials/the-underlying-neural-mechanism-of-tms-in-improving-the-imbalance-of-microbiota-brain-gut-axis-in-alzheimer-s-disease-po-62076https://curecurrent.com/trials/tau-networks-in-psychotic-alzheimer-39-s-disease-62077https://curecurrent.com/trials/utilizing-senior-companions-to-enhance-dementia-care-62078https://curecurrent.com/trials/phase-2-estimation-study-of-fixed-dose-drugs-combination-type-of-polypill-62079https://curecurrent.com/trials/communityrx-dementia-peer-navigation-crxdpeer-62080https://curecurrent.com/trials/treating-hyperexcitability-in-ad-with-levetiracetam-62081https://curecurrent.com/trials/the-swedish-biofinder-2-study-62082https://curecurrent.com/trials/the-swedish-biofinder-memory-clinic-study-62083https://curecurrent.com/trials/digital-application-for-stroke-health-62084https://curecurrent.com/trials/reduce-loneliness-in-care-partners-of-persons-with-ad-adrd-62085https://curecurrent.com/trials/the-swedish-biofinder-primary-care-study-62086https://curecurrent.com/trials/the-swedish-biofinder-preclinical-ad-study-62087https://curecurrent.com/trials/selective-pet-imaging-of-astrocytes-and-microglia-in-alzheimer-s-disease-62088https://curecurrent.com/trials/development-of-an-outcome-score-for-patients-with-knee-osteoarthritis-and-knee-joint-endoprosthesis-using-an-app-62089https://curecurrent.com/trials/study-to-evaluate-the-relative-bioavailability-of-a-new-formulation-of-npt-2042-soft-gelatin-capsules-compared-to-the-or-62090https://curecurrent.com/trials/autobiographical-specificity-62091https://curecurrent.com/trials/ultra-high-resolution-pet-in-aging-neurodegeneration-and-psychotic-disorders-62092https://curecurrent.com/trials/the-digital-memory-notebook-62093https://curecurrent.com/trials/effects-of-real-vs-soundless-acoustic-stimulation-during-deep-sleep-on-brain-activity-memory-and-blood-biomarkers-in-old-62094https://curecurrent.com/trials/a-study-of-jnj-63733657-in-participants-with-early-alzheimer-s-disease-62095https://curecurrent.com/trials/rifaximin-ssd-in-dementia-trial-62096https://curecurrent.com/trials/effectiveness-of-televr-app-in-cognitive-decline-and-mci-patients-62097https://curecurrent.com/trials/multidisciplinary-expert-system-for-the-assessment-management-of-complex-brain-disorders-62098https://curecurrent.com/trials/ketone-ester-effects-on-biomarkers-of-brain-metabolism-and-cognitive-performance-in-cognitively-intact-adults-55-years-o-62099https://curecurrent.com/trials/multi-modal-neuroimaging-in-alzheimer-s-disease-imap-62100https://curecurrent.com/trials/efficacy-of-lecanemab-at-different-therapeutic-doses-for-alzheimer-s-disease-ad-in-real-world-practice-62101https://curecurrent.com/trials/senolytic-therapy-to-modulate-the-progression-of-alzheimer-s-disease-stomp-ad-study-62102https://curecurrent.com/trials/comparison-of-the-effectiveness-of-treadmill-based-walking-and-dual-task-walking-training-in-alzheimer-s-disease-62103https://curecurrent.com/trials/gamma-frequency-stimulation-in-individuals-with-down-syndrome-62104https://curecurrent.com/trials/assessment-of-sleep-disturbance-in-alzheimer-disease-62105https://curecurrent.com/trials/using-exercise-and-electrical-brain-stimulation-to-improve-memory-in-dementia-62106https://curecurrent.com/trials/sleep-aging-and-risk-for-alzheimer-s-2-0-62107https://curecurrent.com/trials/chronic-treatment-of-alzheimer-s-disease-by-gamma-light-and-sound-therapy-62108https://curecurrent.com/trials/the-lifestyle-and-empowerment-techniques-in-survivorship-of-gynecologic-oncology-study-62109https://curecurrent.com/trials/connect-home-alzheimer-s-disease-and-related-dementias-62110https://curecurrent.com/trials/davos-alzheimer-s-collaborative-study-sequential-administration-of-digital-testing-to-screen-for-cognitive-impairment-fo-62111https://curecurrent.com/trials/safety-and-efficacy-of-l-lactis-ckdb001-in-subjects-with-early-alzheimer-s-disease-62112https://curecurrent.com/trials/cannabidiol-solution-for-the-treatment-of-behavioral-symptoms-in-older-adults-with-mild-cognitive-impairment-or-alzheime-62113https://curecurrent.com/trials/the-comparative-effectiveness-dementia-alzheimer-s-registry-62114https://curecurrent.com/trials/siesta-sleep-intervention-to-enhance-cognitive-status-and-reduce-beta-amyloid-62115https://curecurrent.com/trials/a-dyadic-sleep-intervention-for-alzheimer-s-disease-patients-and-their-caregivers-62116https://curecurrent.com/trials/precision-medicine-in-alzheimer-s-disease-integration-of-resilience-metrics-and-risk-factors-validation-cohort-biocogban-62117https://curecurrent.com/trials/early-stage-partner-in-care-living-alone-plus-62118https://curecurrent.com/trials/study-of-av-1959d-an-amyloid-beta-vaccine-62119https://curecurrent.com/trials/brain-effects-of-gamma-frequency-sensory-stimulation-40hz-light-sound-and-other-devices-62120https://curecurrent.com/trials/neurological-soft-signs-in-neurodegenerative-dementias-62121https://curecurrent.com/trials/deep-cervical-lymphatic-venous-anastomosis-for-alzheimer-s-disease-62122https://curecurrent.com/trials/cognitive-stimulation-in-older-adults-with-alzheimer-s-disease-62123https://curecurrent.com/trials/a-graphene-far-infrared-intervention-study-of-cognitive-status-in-older-adults-62124https://curecurrent.com/trials/developing-a-communication-intervention-for-people-with-memory-challenges-and-their-care-partners-62125https://curecurrent.com/trials/brain-nad-in-alzheimer-s-disease-62126https://curecurrent.com/trials/enhancing-triadic-communication-about-cognition-for-older-adults-with-alzheimer-s-disease-or-related-dementias-facing-a-62127https://curecurrent.com/trials/a-study-of-qlh2405-in-healthy-participants-and-participants-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-an-62128https://curecurrent.com/trials/autophagy-and-pathological-aging-62129https://curecurrent.com/trials/visuospatial-attention-eye-movements-and-instrumental-activities-of-daily-living-iadls-in-alzheimer-s-disease-62130https://curecurrent.com/trials/impact-of-ketoflex-12-3-diet-on-early-to-mid-stage-alzheimer-s-progression-62131https://curecurrent.com/trials/cognitive-stimulation-therapy-for-dementia-a-two-armed-pragmatic-trial-62132https://curecurrent.com/trials/the-ketogenic-diet-in-the-treatment-of-alzheimer-s-disease-62133https://curecurrent.com/trials/the-chinese-familial-alzheimer-s-network-62134https://curecurrent.com/trials/detection-of-alzheimer-s-disease-ad-related-seeds-for-ad-diagnosis-62135https://curecurrent.com/trials/theta-burst-stimulation-on-cognitive-function-in-the-patients-with-young-onset-alzheimer-s-disease-dementia-62136https://curecurrent.com/trials/the-diagnostic-cut-off-value-of-core-biomarkers-of-alzheimer-s-disease-62137https://curecurrent.com/trials/study-on-biomarkers-for-early-diagnosis-of-alzheimer-s-disease-62138https://curecurrent.com/trials/china-cognition-and-aging-study-62139https://curecurrent.com/trials/cognitive-effects-of-theta-burst-stimulation-tbs-in-suspected-non-alzheimer-disease-pathophysiology-snap-62140https://curecurrent.com/trials/a-study-to-compare-two-different-sleep-tests-in-participants-with-no-symptoms-or-early-symptoms-of-alzheimer-s-disease-62141https://curecurrent.com/trials/tms-in-preclinical-and-prodromal-ad-modulation-of-brain-networks-and-memory-62142https://curecurrent.com/trials/using-technology-to-support-care-partners-for-persons-with-alzheimer-s-disease-tele-stella-62143https://curecurrent.com/trials/dementia-in-fiction-and-clinical-narratives-62144https://curecurrent.com/trials/the-dose-finding-study-of-daoib-added-to-tdcs-for-ad-62145https://curecurrent.com/trials/global-collaborative-research-on-establishing-a-korean-cognitive-aging-cohort-62146https://curecurrent.com/trials/age-related-hearing-loss-and-lexical-disorders-62147https://curecurrent.com/trials/evaluation-of-a-neuropsychological-tool-to-assess-temporal-processing-abilities-in-alzheimer-s-disease-62148https://curecurrent.com/trials/determining-postoperative-recovery-and-the-impact-of-adverse-events-in-neurosurgery-based-on-self-reported-app-based-lon-62149https://curecurrent.com/trials/novel-augmentation-of-daoib-and-antioxidant-for-early-dementia-62150https://curecurrent.com/trials/masc-reducing-stress-for-caregivers-62151https://curecurrent.com/trials/early-detection-of-alzheimer-s-disease-and-affective-disorders-by-automated-voice-and-speech-analysis-plata-62152https://curecurrent.com/trials/a-study-of-ly3002813-in-participants-with-early-symptomatic-alzheimer-s-disease-trailblazer-alz-62153https://curecurrent.com/trials/induction-and-stabilization-of-gamma-oscillations-with-40-hz-external-brain-stimulation-62154https://curecurrent.com/trials/40-hz-transcranial-alternating-current-stimulation-for-inducing-gamma-oscillations-62155https://curecurrent.com/trials/using-equine-therapy-in-dementia-cognitive-stimulation-62156https://curecurrent.com/trials/art-of-memory-for-cognitive-enhancement-in-the-monza-brain-health-service-62157https://curecurrent.com/trials/toward-molecular-profiling-of-parkinson-s-disease-in-easily-accessible-biological-matrices-62158https://curecurrent.com/trials/effects-of-dance-and-music-appreciation-on-brain-health-and-fitness-in-people-at-risk-for-alzheimer-s-disease-62159https://curecurrent.com/trials/lombard-cohort-of-brain-health-services-62160https://curecurrent.com/trials/assessment-of-malnutrition-in-hospitalized-patients-a-quasi-study-62161https://curecurrent.com/trials/allopregnanolone-regenerative-therapeutic-for-early-alzheimer-s-disease-intramuscular-study-62162https://curecurrent.com/trials/dementia-caregivers-link-to-assistance-and-resources-62163https://curecurrent.com/trials/social-cognitive-functioning-validation-of-a-new-neuropsychological-test-62164https://curecurrent.com/trials/monitoring-of-early-disease-progression-in-hereditary-transthyretin-amyloidosis-62165https://curecurrent.com/trials/cogscreen-ii-early-detection-of-cognitive-impairment-62166https://curecurrent.com/trials/speech-pattern-evaluation-and-analysis-for-knowledge-of-ad-62167https://curecurrent.com/trials/alzheimer-s-disease-neuroimaging-initiative-3-62168https://curecurrent.com/trials/system-igf-1-pathway-and-alzheimer-s-disease-62169https://curecurrent.com/trials/brain-outcomes-with-lifestyle-change-in-down-syndrome-62170https://curecurrent.com/trials/gamma-induction-for-alzheimer-s-disease-62171https://curecurrent.com/trials/returning-research-results-that-indicate-risk-of-alzheimer-disease-dementia-to-healthy-participants-in-longitudinal-stud-62172https://curecurrent.com/trials/mild-cognitive-impairment-community-screening-and-early-intervention-via-stem-cell-therapy-and-wearable-brain-computer-i-62173https://curecurrent.com/trials/prospective-single-arm-safety-study-of-cervical-lva-in-ad-patients-62174https://curecurrent.com/trials/arlington-longitudinal-optimal-healthy-aging-study-aloha-62175https://curecurrent.com/trials/digital-accessible-remote-olfactory-mediated-health-assessments-for-preclinical-ad-62176https://curecurrent.com/trials/making-antibody-treatments-more-effective-in-early-alzheimer-s-disease-using-3tesla-magnetica-resonance-62177https://curecurrent.com/trials/web-based-psycho-educational-program-to-support-carers-of-alzheimer-s-patients-62178https://curecurrent.com/trials/anxiety-sensitivity-treatment-to-reduce-anxiety-in-alzheimer-s-62179https://curecurrent.com/trials/nicotinic-acid-for-the-treatment-of-alzheimer-s-disease-62180https://curecurrent.com/trials/a-community-based-screening-program-to-identify-participants-at-high-risk-for-amyloid-pathology-62181https://curecurrent.com/trials/48-hour-ambulatory-eeg-monitoring-in-early-onset-alzheimer-s-disease-62182https://curecurrent.com/trials/autonomous-navigating-robot-for-detecting-falls-and-risk-of-falls-in-nursing-home-residents-with-alzheimer-disease-adrd-62183https://curecurrent.com/trials/testing-refinement-of-carepair-an-assessment-and-referral-platform-to-support-family-caregivers-of-alzheimer-s-disease-a-62184https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-efficacy-of-lecanemab-in-subjects-with-early-alzheimer-s-disease-62185https://curecurrent.com/trials/repurposing-siponimod-for-alzheimer-s-disease-62186https://curecurrent.com/trials/locomotion-adaptation-deficits-in-older-adults-with-mild-cognitive-impairment-and-alzheimers-disease-62187https://curecurrent.com/trials/10-year-survival-after-acute-hip-fracture-in-patients-with-preclinical-clinical-alzheimer-pathology-62188https://curecurrent.com/trials/ed-lead-emergency-departments-leading-the-transformation-of-alzheimer-s-and-dementia-care-62189https://curecurrent.com/trials/an-open-label-extension-of-xpro1595-in-patients-with-alzheimer-s-disease-62190https://curecurrent.com/trials/home-based-tdcs-in-frontotemporal-dementia-or-alzheimer-s-disease-62191https://curecurrent.com/trials/daratumumab-pomalidomide-and-dexamethasone-dpd-in-relapsed-refractory-light-chain-amyloidosis-patients-previously-expose-62192https://curecurrent.com/trials/couples-lived-experience-62193https://curecurrent.com/trials/improving-sleep-and-ad-biomarkers-62194https://curecurrent.com/trials/blood-biomarkers-for-alzheimer-disease-and-neuro-injury-to-estimate-the-association-with-cognitive-functional-decline-an-62195https://curecurrent.com/trials/to-evaluate-the-efficacy-safety-and-tolerability-of-dronabinol-oral-solution-for-agitation-in-patients-with-alzheimer-s-62196https://curecurrent.com/trials/comparative-study-of-high-performance-low-cost-optical-coherence-tomography-stage-1b-2-and-3-62197https://curecurrent.com/trials/a-long-term-extension-study-to-evaluate-safety-tolerability-and-efficacy-of-al002-in-alzheimer-s-disease-62198https://curecurrent.com/trials/german-dementia-registry-62199https://curecurrent.com/trials/pharmacological-enhancement-of-glymphatic-function-in-humans-62200https://curecurrent.com/trials/cuhk-brain-health-longitudinal-study-62201https://curecurrent.com/trials/dementia-and-storytelling-in-vietnam-62202https://curecurrent.com/trials/risk-screening-primary-prevention-of-elder-abuse-in-people-living-with-dementia-62203https://curecurrent.com/trials/generation-of-synthetic-18f-fdg-pet-from-early-phase-amyloid-pet-in-alzheimer-s-disease-62204https://curecurrent.com/trials/improv-music-therapy-for-older-adults-62205https://curecurrent.com/trials/physical-activity-and-community-empowerment-project-62206https://curecurrent.com/trials/retrospective-observational-study-of-blood-based-biomarkers-in-the-diagnosis-and-monitoring-of-patients-with-a-neurodege-62207https://curecurrent.com/trials/speech-and-language-interventions-for-italian-people-with-ppa-62208https://curecurrent.com/trials/evaluate-the-use-of-18f-apn-1607-pet-in-subjects-with-ad-related-cognitive-impairment-and-subjects-with-normal-cognitive-62209https://curecurrent.com/trials/tms-for-cognitive-decline-in-aging-and-preclinical-ad-62210https://curecurrent.com/trials/hero-a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-pk-and-pharmacodynamics-pd-of-ion269-in-participan-62211https://curecurrent.com/trials/exercise-to-improve-brain-health-in-older-african-americans-62212https://curecurrent.com/trials/alzheimer-s-registry-62213https://curecurrent.com/trials/circadian-rhythm-and-other-factors-in-memory-clinic-patients-62214https://curecurrent.com/trials/pilot-study-of-studyu-for-n-of-1-trials-in-hfref-patients-n-of-1-app-62215https://curecurrent.com/trials/clinical-study-on-deep-cervical-lymphatic-trunk-decompression-combined-with-mid-cervical-deep-lymph-node-external-jugula-62216https://curecurrent.com/trials/biomind-biomarkers-for-the-molecular-identification-of-neurodegenerative-dementia-improving-access-to-alzheimer-s-diseas-62217https://curecurrent.com/trials/satisfaction-with-orodispersible-vs-conventional-memantine-in-moderate-to-severe-alzheimer-s-disease-62218https://curecurrent.com/trials/precision-medicine-approach-for-early-dementia-mild-cognitive-impairment-62219https://curecurrent.com/trials/donepezil-versus-non-drug-treatment-in-alzheimer-s-disease-62220https://curecurrent.com/trials/rct-of-heartbot-in-women-62221https://curecurrent.com/trials/evaluation-of-scale-pet-software-for-quantitative-brain-pet-analysis-in-alzheimer-s-disease-62222https://curecurrent.com/trials/vr-pupillometry-in-cognitive-impairment-62223https://curecurrent.com/trials/comparing-structured-retrieval-practice-and-reading-based-education-for-dementia-caregivers-62224https://curecurrent.com/trials/evaluation-of-a-self-compassion-app-in-people-with-cancer-feasibility-acceptability-and-changes-in-well-being-62225https://curecurrent.com/trials/investigating-the-impact-of-duration-and-amount-of-light-on-the-circadian-system-response-aim-3-62226https://curecurrent.com/trials/triad-tracking-risk-in-integrated-alzheimer-s-diagnostics-62227https://curecurrent.com/trials/app-based-protein-support-for-older-adults-coaching-towards-healthy-ageing-62228https://curecurrent.com/trials/effectiveness-of-genistein-in-mild-cognitive-impairment-62229https://curecurrent.com/trials/assessment-of-informal-support-provided-by-caregivers-at-different-stages-of-alzheimer-s-disease-62230https://curecurrent.com/trials/validation-of-a-digital-intervention-to-rehabilitate-cognitive-resources-62231https://curecurrent.com/trials/a-program-to-reduce-inappropriate-medications-among-older-adults-with-alzheimer-s-disease-implementation-phase-2-62232https://curecurrent.com/trials/evaluating-the-efficacy-of-the-pain-identification-and-communication-toolkit-62233https://curecurrent.com/trials/assessment-of-foralumab-safety-and-modulation-of-microglial-activation-in-alzheimer-s-disease-62234https://curecurrent.com/trials/attenuation-of-postprandial-inflammatory-processes-in-alzheimer-s-disease-patients-by-consumption-of-pomace-oil-62235https://curecurrent.com/trials/early-onset-alzheimer-s-disease-genomic-study-62236https://curecurrent.com/trials/postherpetic-neuralgia-after-herpes-zoster-and-incident-dementia-risk-62237https://curecurrent.com/trials/efficacy-of-virtual-reality-reminiscence-therapy-in-nursing-home-residents-with-alzheimer-s-disease-or-related-diseases-62238https://curecurrent.com/trials/feasibility-of-wearables-in-dementia-care-in-rural-taiwan-62239https://curecurrent.com/trials/the-signature-of-alzheimer-s-disease-in-subjective-cognitive-decline-62240https://curecurrent.com/trials/phosphorylated-tau-levels-in-donated-blood-62241https://curecurrent.com/trials/auditory-stimulation-during-sleep-to-enhance-long-term-memory-in-amnestic-mci-62242https://curecurrent.com/trials/advancing-alzheimer-s-care-home-based-tdcs-for-affective-symptoms-62243https://curecurrent.com/trials/blood-biomarkers-for-early-and-accurate-diagnosis-of-alzheimer-s-disease-in-primary-care-62244https://curecurrent.com/trials/a-study-of-e2814-with-concurrent-lecanemab-treatment-in-participants-with-early-alzheimer-s-disease-62245https://curecurrent.com/trials/ala-enriched-nutrition-for-prevention-of-cognitive-decline-in-apoe4-older-adults-62246https://curecurrent.com/trials/clarifying-abcb1-s-role-in-alzheimer-s-disease-62247https://curecurrent.com/trials/combined-metabolic-activator-supplementation-in-subjects-diagnosed-with-alzheimer-s-disease-62248https://curecurrent.com/trials/tennessee-alzheimer-s-project-62249https://curecurrent.com/trials/use-of-wearables-for-identifying-factors-associated-with-mild-cognitive-impairment-and-early-stage-alzheimer-s-disease-62250https://curecurrent.com/trials/research-study-for-patients-with-neurological-diseases-which-evaluates-the-patient-experience-of-the-memorem-device-62251https://curecurrent.com/trials/benefits-of-strength-training-in-informal-caregivers-of-patients-with-alzheimer-s-disease-62252https://curecurrent.com/trials/project-care-d-online-caregiver-education-for-dementia-62253https://curecurrent.com/trials/perturbation-training-reduces-falls-in-people-with-alzheimer-s-disease-ad-62254https://curecurrent.com/trials/retinal-imaging-in-neurodegenerative-disease-62255https://curecurrent.com/trials/a-study-of-neurodegeneration-and-neuronal-fluctuations-in-lewy-body-disease-and-alzheimer-s-disease-62256https://curecurrent.com/trials/radialis-pet-imager-for-the-assessment-of-neuritic-amyloid-plaque-burden-62257https://curecurrent.com/trials/new-ideas-imaging-dementia-evidence-for-amyloid-scanning-study-62258https://curecurrent.com/trials/open-label-extension-study-in-participants-with-early-alzheimer-s-disease-62259https://curecurrent.com/trials/quantification-of-hsp90-in-the-human-brain-62260https://curecurrent.com/trials/dementia-prevention-internet-based-intervention-randomized-controlled-trial-and-knowledge-translation-62261https://curecurrent.com/trials/stim-pet-biomarker-education-disclosure-62262https://curecurrent.com/trials/lethe-at-a-personalized-multidomain-lifestyle-intervention-for-individuals-at-increased-risk-of-memory-impairment-62263https://curecurrent.com/trials/brain-health-the-microbiome-62264https://curecurrent.com/trials/the-getting-off-app-for-methamphetamine-using-gay-and-bisexual-men-62265https://curecurrent.com/trials/cognitive-vulnerability-to-stress-in-individuals-at-risk-for-alzheimer-s-disease-62266https://curecurrent.com/trials/nabilone-for-agitation-blinded-intervention-trial-62267https://curecurrent.com/trials/pet-brain-imaging-in-multiple-sclerosis-alzheimer-s-disease-and-other-neurological-and-neuropsychiatric-diseases-62268https://curecurrent.com/trials/feasibility-of-lecanemab-registry-and-clinical-outcome-measures-62269https://curecurrent.com/trials/memori-corps-activity-based-companion-care-for-dementia-62270https://curecurrent.com/trials/epileptic-hippocampus-in-alzheimer-s-disease-62271https://curecurrent.com/trials/a-trial-evaluating-the-effect-of-nio752-on-tau-synthesis-measured-by-a-process-known-as-silk-62272https://curecurrent.com/trials/diminishing-accelerated-long-term-forgetting-in-mild-cognitive-impairment-62273https://curecurrent.com/trials/discovery-of-novel-biomarkers-that-will-lead-to-the-early-detection-of-alzheimer-s-disease-62274https://curecurrent.com/trials/sweet-night-musical-diffusion-by-caregivers-effects-of-musical-diffusion-by-caregivers-on-sleep-onset-and-behavioral-reg-62275https://curecurrent.com/trials/a-post-marketing-study-in-participants-with-early-alzheimer-s-disease-treated-with-lecanemab-62276https://curecurrent.com/trials/biomarker-exploration-in-aging-cognition-and-neurodegeneration-62277https://curecurrent.com/trials/deciphering-the-effect-of-moderate-wine-consumption-on-healthy-aging-through-postprandial-extracellular-vesicles-62278https://curecurrent.com/trials/self-care-for-dementia-caregivers-62279https://curecurrent.com/trials/safety-and-feasibility-of-exablate-blood-brain-barrier-disruption-for-mild-cognitive-impairment-or-mild-alzheimer-s-dise-62280https://curecurrent.com/trials/upenn-observational-research-repository-on-neurodegenerative-disease-62281https://curecurrent.com/trials/collaborative-care-coordination-program-for-alzheimer-s-disease-and-related-dementias-62282https://curecurrent.com/trials/digital-interventions-in-neuro-rehabilitation-gotcha-62283https://curecurrent.com/trials/neurocognitive-assessment-platform-4-alzheimer-62284https://curecurrent.com/trials/effectiveness-of-the-safe-haven-application-app-among-undergraduates-62285https://curecurrent.com/trials/cardiovascular-risk-assessment-in-young-women-after-index-pregnancy-with-and-without-placental-complications-62286https://curecurrent.com/trials/ultrasound-guided-stellate-ganglion-block-for-alzheimer-s-disease-62287https://curecurrent.com/trials/amyloid-beta-peptide-1-40-and-alzheimer-s-disease-62288https://curecurrent.com/trials/cognitive-health-in-ageing-register-investigational-and-observational-trial-studies-in-dementia-research-chariot-prospec-62289https://curecurrent.com/trials/a-donanemab-ly3002813-study-in-participants-with-preclinical-alzheimer-s-disease-trailblazer-alz-3-62290https://curecurrent.com/trials/exablate-blood-brain-barrier-opening-for-treatment-of-alzheimer-s-disease-62291https://curecurrent.com/trials/erythrocyte-complement-receptor-1-and-alzheimer-disease-62292https://curecurrent.com/trials/make-better-choices-2-for-rural-appalachians-62293https://curecurrent.com/trials/mir-342-5p-ankg-pathway-in-early-ad-synaptic-dysfunction-62294https://curecurrent.com/trials/evaluating-the-feasibility-of-ellefa-app-implementation-62295https://curecurrent.com/trials/comprehensive-assessment-of-neurodegeneration-and-dementia-62296https://curecurrent.com/trials/evaluation-of-a-plasma-marker-p-tau217-for-the-biological-diagnosis-of-alzheimer-s-disease-and-comparison-with-csf-marke-62297https://curecurrent.com/trials/feasibility-and-interest-of-the-3d-ephemeris-for-temporal-orientation-in-alzheimer-s-pilot-study-62298https://curecurrent.com/trials/a-study-of-nh280105-in-healthy-adult-participants-62299https://curecurrent.com/trials/bumetanide-in-patients-with-alzheimer-s-disease-62300https://curecurrent.com/trials/evaluation-of-self-mediated-alternatives-for-risk-testing-education-and-return-of-results-62301https://curecurrent.com/trials/the-use-of-memantine-for-prevention-of-alzheimer-s-disease-62302https://curecurrent.com/trials/speech-derived-digital-biomarkers-study-62303https://curecurrent.com/trials/mr-elastography-of-cognitive-impairment-62304https://curecurrent.com/trials/brain-health-registry-an-online-registry-to-identify-and-assess-subjects-for-brain-research-62305https://curecurrent.com/trials/cervical-lymphatico-venous-bypass-for-treatment-of-alzheimer-s-disease-proof-of-concept-study-clyveb-ad-1-study-62306https://curecurrent.com/trials/novel-personalized-non-invasive-combined-magnetic-and-electrical-stimulation-of-the-dmn-in-mild-ad-patients-62307https://curecurrent.com/trials/illuminating-neuropsychological-dysfunction-and-systemic-inflammatory-mechanisms-gleaned-after-hospitalization-in-trauma-62308https://curecurrent.com/trials/levetiracetam-to-prevent-seizures-in-symptomatic-alzheimer-s-disease-in-adults-with-down-syndrome-62309https://curecurrent.com/trials/palliative-care-educator-62310https://curecurrent.com/trials/vestibular-therapy-in-alzheimer-s-disease-62311https://curecurrent.com/trials/non-invasive-brain-stimulation-for-cognitive-and-motor-dysfunction-in-dementia-62312https://curecurrent.com/trials/impact-of-a-multicomponent-exercise-program-on-cognitive-and-functional-outcomes-in-patients-with-mild-cognitive-impairm-62313https://curecurrent.com/trials/exablate-blood-brain-barrier-bbb-disruption-for-the-treatment-of-alzheimer-s-disease-62314https://curecurrent.com/trials/heart-rate-and-breathing-effects-on-attention-and-memory-62315https://curecurrent.com/trials/efficacy-of-paper-based-cognitive-training-in-vietnamese-patients-with-early-alzheimer-s-disease-62316https://curecurrent.com/trials/exploring-the-gut-brain-axis-in-ageing-and-neurodegeneration-62317https://curecurrent.com/trials/effect-of-cervical-lymphaticovenous-and-lymph-node-to-vein-anastomosis-in-patients-with-intracranial-lymphatic-circulati-62318https://curecurrent.com/trials/in-vivo-pet-of-synaptic-density-in-cognitive-disorders-62319https://curecurrent.com/trials/positive-psychology-for-early-cognitive-decline-effects-on-cognitive-and-brain-function-62320https://curecurrent.com/trials/innate-immunity-stimulation-via-tlr9-in-early-ad-62321https://curecurrent.com/trials/tms-pilot-in-early-ad-ii-62322https://curecurrent.com/trials/investigator-initiated-trial-of-galcanezumab-treatment-in-alzheimer-s-disease-62323https://curecurrent.com/trials/clinical-analgesic-management-in-dementia-62324https://curecurrent.com/trials/daridorexant-to-prevent-post-cardiotomy-delirium-62325https://curecurrent.com/trials/a-clinical-trial-to-study-single-and-multiple-doses-of-gsm-779690t-in-healthy-participants-62326https://curecurrent.com/trials/establishing-clinical-utility-evidence-for-a-novel-alzheimer-s-disease-blood-based-biomarker-assay-62327https://curecurrent.com/trials/a-trial-to-test-intermittent-deep-brain-stimulation-of-nucleus-basalis-of-meynert-to-treat-alzheimers-62328https://curecurrent.com/trials/evaluation-of-the-safety-tolerability-and-pharmacokinetics-of-j4-in-healthy-adults-62329https://curecurrent.com/trials/clinical-evaluation-on-the-therapeutic-effect-of-acupuncture-treatment-for-alzheimer-s-disease-62330https://curecurrent.com/trials/mr-evaluation-of-cerebrospinal-fluid-csf-dynamics-62331https://curecurrent.com/trials/trial-to-reduce-antimicrobial-use-in-nursing-home-residents-with-alzheimer-s-disease-and-other-dementias-2-0-62332https://curecurrent.com/trials/effects-of-heart-rate-oscillations-during-meditation-on-plasma-biomarkers-of-alzheimer-s-disease-62333https://curecurrent.com/trials/network-based-biomarker-discovery-of-neurodegenerative-diseases-using-multimodal-connectivity-62334https://curecurrent.com/trials/normative-database-and-test-retest-reliability-for-braincheck-assessments-62335https://curecurrent.com/trials/a-study-of-silkworm-pupa-powder-intervention-in-the-nutritional-status-of-patients-with-alzheimer-s-disease-62336https://curecurrent.com/trials/antiplatelet-use-in-dementia-subtypes-62337https://curecurrent.com/trials/video-telehealth-in-alzheimer-s-neuropsychology-vital-np-62338https://curecurrent.com/trials/the-aging-brain-answers-program-62339https://curecurrent.com/trials/validation-of-blood-biomarkers-for-alzheimer-s-disease-62340https://curecurrent.com/trials/training-app-for-inhibitory-control-towards-food-62341https://curecurrent.com/trials/phase-3-clinical-trial-of-wujia-yizhi-granules-in-the-treatment-of-mild-to-moderate-alzheimer-s-dementia-syndrome-of-def-62342https://curecurrent.com/trials/a-biomarker-chip-assay-in-preserved-red-blood-cells-for-the-diagnosis-of-alzheimer-s-disease-62343https://curecurrent.com/trials/remote-tdcs-and-chair-yoga-for-chronic-knee-pain-in-alzheimer-s-patients-62344https://curecurrent.com/trials/a-clinical-trial-of-ak152-in-healthy-volunteers-and-patients-with-alzheimer-s-disease-62345https://curecurrent.com/trials/study-of-biodistribution-metabolism-excretion-and-brain-uptake-18f-jss20-183a-62346https://curecurrent.com/trials/life-enhancing-activities-for-family-caregivers-leaf-2-0-62347https://curecurrent.com/trials/low-intensity-hippocampal-transcranial-ultrasound-stimulation-for-managing-cognitive-and-sleep-dysfunction-in-preclinica-62348https://curecurrent.com/trials/incremental-diagnostic-value-of-tau-pet-with-18f-ro948-vs-amyloid-pet-in-patients-with-cognitive-impairment-62349https://curecurrent.com/trials/improving-family-quality-of-life-through-training-to-reduce-care-resistant-behaviors-by-people-with-ad-and-tbi-62350https://curecurrent.com/trials/traumatic-brain-injury-and-alzheimer-s-disease-related-dementias-caregiver-support-intervention-62351https://curecurrent.com/trials/biodistribution-of-11c-pib-in-patients-with-risk-factors-for-alzheimer-s-disease-62352https://curecurrent.com/trials/exploratory-clinical-study-and-validation-of-blood-biomarkers-for-alzheimer-s-disease-62353https://curecurrent.com/trials/videofluoroscopic-swallowing-study-vfss-62354https://curecurrent.com/trials/daridorexant-for-alzheimer-disease-prevention-62355https://curecurrent.com/trials/clinical-trial-on-alzheimer-disease-presbycusis-and-hearing-aids-62356https://curecurrent.com/trials/extension-study-of-participants-from-spg302-alz-101-62357https://curecurrent.com/trials/evaluation-of-the-effectiveness-and-safety-of-transcranial-direct-current-stimulation-in-combination-with-nasal-near-inf-62358https://curecurrent.com/trials/family-caregiver-online-survey-dementia-and-swallowing-difficulties-62359https://curecurrent.com/trials/tributyrin-treatment-in-mild-alzheimer-disease-assessment-of-butyrate-effects-via-the-gut-brain-62360https://curecurrent.com/trials/a-food-effect-study-of-ly03020-in-healthy-subjects-62361https://curecurrent.com/trials/biomarker-effects-of-alz-801-in-apoe4-carriers-with-early-alzheimer-s-disease-62362https://curecurrent.com/trials/glymphatic-function-tms-study-62363https://curecurrent.com/trials/music-therapy-experiences-in-patients-with-mild-cognitive-impairment-mci-and-alzheimer-s-disease-ad-62364https://curecurrent.com/trials/the-porchlight-project-62365https://curecurrent.com/trials/a-pilot-study-to-examine-the-effect-of-egb761-on-plasma-biomarker-levels-and-on-cognitive-function-in-patients-with-mci-62366https://curecurrent.com/trials/study-of-factors-influencing-post-stroke-dementia-62367https://curecurrent.com/trials/event-related-potential-erp-components-in-clinical-diagnosis-62368https://curecurrent.com/trials/digital-technology-combined-with-blood-marker-screening-and-diagnosis-for-community-populations-based-on-classification-62369https://curecurrent.com/trials/palliative-care-for-persons-with-late-stage-alzheimer-s-and-related-dementias-and-their-caregivers-62370https://curecurrent.com/trials/clinical-utility-of-early-vs-late-blood-biomarker-testing-for-alzheimer-s-disease-62371https://curecurrent.com/trials/alzheimer-s-prevention-registry-a-program-to-accelerate-enrollment-into-studies-62372https://curecurrent.com/trials/study-of-indoor-air-pollutants-and-their-impact-in-childhood-health-and-wellbeing-62373https://curecurrent.com/trials/improving-executive-control-in-cognitively-healthy-older-adults-the-multitasking-strategy-must-study-62374https://curecurrent.com/trials/a-pilot-study-of-the-effects-of-bcg-immunization-on-csf-and-blood-based-biomarkers-in-older-adults-62375https://curecurrent.com/trials/a-trial-to-evaluate-the-efficacy-and-safety-of-pq912-in-patients-with-early-ad-62376https://curecurrent.com/trials/combined-brain-stimulation-and-methylphenidate-treatment-for-apathy-in-dementia-62377https://curecurrent.com/trials/aligning-patient-preferences-a-role-offering-alzheimer-s-patients-caregivers-and-healthcare-providers-education-and-supp-62378https://curecurrent.com/trials/testing-the-effects-of-a-text-message-caregiver-support-intervention-for-latinos-62379https://curecurrent.com/trials/understanding-mechanisms-of-synaptic-degeneration-underlying-clinical-symptoms-in-patients-with-mds-and-nds-62380https://curecurrent.com/trials/effects-of-exercise-on-functional-ability-in-people-with-dementia-in-nursing-homes-a-cluster-randomised-controlled-trial-62381https://curecurrent.com/trials/a-study-to-assess-safety-of-abbv-916-and-how-intravenous-abbv-916-moves-through-body-and-affects-brain-amyloid-plaque-cl-62382https://curecurrent.com/trials/efficacy-and-safety-of-dmb-i-inn-latrepirdine-in-patients-with-alzheimer-type-dementia-62383https://curecurrent.com/trials/genematch-a-program-of-the-alzheimer-s-prevention-registry-to-match-individuals-to-studies-based-on-apolipoprotein-e-apo-62384https://curecurrent.com/trials/evaluation-of-a-finger-prick-collection-method-for-measuring-alzheimer-s-disease-blood-biomarkers-62385https://curecurrent.com/trials/early-stage-of-alzheimer-s-and-parkinson-s-diseases-hearing-relevance-saphir-62386https://curecurrent.com/trials/draw-10-a-weekly-blood-draw-study-to-understand-the-biological-variability-of-plasma-ptau-217-62387https://curecurrent.com/trials/transcranial-photobiomodulation-for-alzheimer-s-disease-trap-ad-62388https://curecurrent.com/trials/a-study-to-assess-the-long-term-safety-and-efficacy-of-axs-05-in-subjects-with-alzheimer-s-disease-agitation-62389https://curecurrent.com/trials/relationship-between-alzheimer-disease-and-diminution-of-the-three-macular-nervous-retinal-layers-62390https://curecurrent.com/trials/infrared-light-for-memory-loss-in-mild-cognitive-impairment-mci-62391https://curecurrent.com/trials/can-optical-coherence-tomography-pictures-of-the-retina-detect-alzheimer-s-disease-at-its-earliest-stages-62392https://curecurrent.com/trials/longitudinal-study-to-investigate-different-transcranial-electrical-stimulation-62393https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-virtual-reality-headsets-with-hypnotic-scenarios-for-hygiene-care-in-patients-with-al-62394https://curecurrent.com/trials/a-single-center-self-controlled-prospective-case-series-pilot-study-to-assess-the-effect-of-lamivudine-3tc-on-neurocogni-62395https://curecurrent.com/trials/effect-of-physiologic-insulin-administration-on-insulin-sensitivity-and-cognition-62396https://curecurrent.com/trials/music-social-attention-and-dementia-62397https://curecurrent.com/trials/a-phase-2a-study-to-investigate-rem0046127-in-mild-to-moderate-alzheimer-s-disease-62398https://curecurrent.com/trials/predictors-of-emergency-department-use-in-frail-patients-62399https://curecurrent.com/trials/an-investigation-into-the-feasibility-of-beetroot-juice-supplementation-in-people-living-with-alzheimer-s-disease-62400https://curecurrent.com/trials/the-effects-of-an-app-based-acupressure-on-alleviating-fatigue-pruritus-and-sleep-quality-among-hemodialysis-patients-62401https://curecurrent.com/trials/n-dose-ad-a-dose-optimization-trial-of-nicotinamide-riboside-in-alzheimer-s-disease-62402https://curecurrent.com/trials/frailty-outcomes-and-risk-with-alzheimer-s-related-dementia-62403https://curecurrent.com/trials/ability-to-drive-of-early-stage-alzheimer-disease-62404https://curecurrent.com/trials/tau-pet-imaging-in-the-aging-brain-cohort-dedicated-to-diversity-study-62405https://curecurrent.com/trials/understanding-the-lived-experience-and-bereavement-of-caregivers-of-people-with-alzheimer-s-disease-62406https://curecurrent.com/trials/characterizing-cognitive-decline-in-late-life-depression-the-adni-depression-project-62407https://curecurrent.com/trials/omics-sciences-for-the-identification-of-pathogenetic-mechanisms-and-biomarkers-in-neurodegenerative-diseases-62408https://curecurrent.com/trials/advantage-of-cerebellar-transcranial-magnetic-stimulation-in-alzheimer-s-diseases-act-ad-62409https://curecurrent.com/trials/microbiota-mediated-flavonoid-metabolites-for-cognitive-health-62410https://curecurrent.com/trials/hears-nps-addressing-hearing-loss-as-a-common-unmet-contributor-of-neuropsychiatric-symptoms-62411https://curecurrent.com/trials/zinde-zihin-program-to-reduce-alzheimer-s-disease-risk-in-adults-aged-65-and-older-62412https://curecurrent.com/trials/sex-specific-effects-of-endocrine-disruption-on-aging-and-alzheimer-s-disease-62413https://curecurrent.com/trials/low-intensity-focused-ultrasound-lifu-neuromodulation-62414https://curecurrent.com/trials/i-care-2-mobile-telehealth-to-reduce-alzheimer-s-related-symptoms-62415https://curecurrent.com/trials/smart-cloth-care-system-for-dementia-62416https://curecurrent.com/trials/real-world-dementia-outcomes-observational-study-62417https://curecurrent.com/trials/effects-on-the-olfactory-epithelium-and-the-olfactory-nerve-from-exposure-to-diesel-exhaust-62418https://curecurrent.com/trials/improving-prognostic-confidence-in-neurodegenerative-diseases-causing-dementia-using-peripheral-biomarkers-and-integrati-62419https://curecurrent.com/trials/effects-of-dual-task-training-in-individuals-with-alzheimer-62420https://curecurrent.com/trials/a-phase-1-mad-study-to-evaluate-the-safety-and-tolerability-of-ly03020-62421https://curecurrent.com/trials/transcranial-photobiomodulation-tpbm-in-alzheimer-s-disease-study-62422https://curecurrent.com/trials/vy7523-102-randomized-placebo-controlled-double-blind-multiple-ascending-dose-study-in-participants-with-early-alzheimer-62423https://curecurrent.com/trials/building-a-bridge-bab-between-clinical-and-community-care-62424https://curecurrent.com/trials/dietary-plant-extracts-colonic-microbes-and-apoe-genetics-interactions-study-62425https://curecurrent.com/trials/tau-pet-outcomes-with-anti-amyloid-immunotherapies-62426https://curecurrent.com/trials/effect-of-periodontal-treatment-on-alzheimer-disease-associated-outcomes-62427https://curecurrent.com/trials/translating-data-science-to-palliative-care-62428https://curecurrent.com/trials/transcranial-alternating-current-stimulation-for-patients-with-mild-alzheimer-s-disease-ii-transform-ad-ii-62429https://curecurrent.com/trials/information-about-alzheimer-s-disease-for-latinos-in-new-york-city-62430https://curecurrent.com/trials/investigation-of-the-relationship-between-periodontitis-and-alzheimer-s-disease-in-terms-of-blood-parameters-62431https://curecurrent.com/trials/napping-sleep-cognitive-decline-and-risk-of-alzheimer-s-disease-62432https://curecurrent.com/trials/study-of-daratumumab-in-patients-with-mild-to-moderate-alzheimer-s-disease-62433https://curecurrent.com/trials/open-label-extension-protocol-to-snk01-ad01-study-62434https://curecurrent.com/trials/promis-and-mobility-evaluation-in-sarcoma-patients-62435https://curecurrent.com/trials/a-multiple-ascending-dose-study-in-healthy-volunteers-and-patients-with-alzheimer-s-disease-62436https://curecurrent.com/trials/passive-sensor-identification-of-digital-biomarkers-to-assess-effects-of-orally-administered-nicotinamide-riboside-62437https://curecurrent.com/trials/care-coordination-system-for-people-with-dementia-62438https://curecurrent.com/trials/sex-specific-risk-factors-and-trajectories-of-blood-biomarkers-for-alzheimer-s-disease-and-related-dementias-62439https://curecurrent.com/trials/u-s-study-to-protect-brain-health-through-lifestyle-intervention-to-reduce-risk-62440https://curecurrent.com/trials/development-of-novel-measures-for-alzheimer-s-disease-prevention-trials-62441https://curecurrent.com/trials/assess-fibrin-in-brains-with-ad-adrd-62442https://curecurrent.com/trials/a-phase-1-safety-and-tolerability-study-of-tml-6-in-healthy-and-elderly-volunteers-for-alzheimer-s-disease-treatment-62443https://curecurrent.com/trials/a-phase-2-study-to-evaluate-efficacy-and-safety-of-al002-in-participants-with-early-alzheimer-s-disease-62444https://curecurrent.com/trials/clinical-trial-protocol-alzheimer-s-dementia-underlying-encephalopathy-62445https://curecurrent.com/trials/spironolactone-safety-in-african-americans-with-mild-cognitive-impairment-and-early-dementia-62446https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-intravenous-sabirnetug-in-participants-with-early-alzheimer-s-disease-altitud-62447https://curecurrent.com/trials/dtms-for-subjective-cognitive-decline-62448https://curecurrent.com/trials/deep-tms-for-comorbid-depression-and-cognitive-impairment-in-older-adults-62449https://curecurrent.com/trials/a-study-of-health-care-use-and-costs-in-participants-with-early-stage-alzheimer-s-disease-ad-62450https://curecurrent.com/trials/old-school-hip-hop-improve-alzheimer-s-disease-knowledge-62451https://curecurrent.com/trials/stimulation-of-cingulo-opercular-alertness-network-62452https://curecurrent.com/trials/gene-therapy-for-apoe4-homozygote-of-alzheimer-s-disease-62453https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-various-anti-inflammatory-agents-in-participants-with-mild-cognitive-impairment-or-m-62454https://curecurrent.com/trials/person-environment-fit-for-persons-with-dementia-62455https://curecurrent.com/trials/study-to-assess-adverse-events-change-in-disease-activity-and-how-oral-abbv-552-capsules-moves-through-the-body-of-parti-62456https://curecurrent.com/trials/long-term-extension-study-of-the-safety-and-efficacy-of-avp-786-for-the-treatment-of-agitation-in-patients-with-dementia-62457https://curecurrent.com/trials/efficacy-and-safety-of-mk-1167-in-participants-with-alzheimer-s-disease-dementia-taking-stable-donepezil-treatment-mk-11-62458https://curecurrent.com/trials/a-light-exposure-tracker-designed-to-improve-circadian-rhythms-aim-1-62459https://curecurrent.com/trials/home-based-transcranial-direct-current-stimulation-tdcs-for-behavioral-symptoms-in-alzheimer-s-disease-and-related-demen-62460https://curecurrent.com/trials/vagus-nerve-stimulation-to-enhance-memory-in-aging-62461https://curecurrent.com/trials/a-real-world-comparative-study-of-donanemab-ly3002813-plus-usual-care-versus-usual-care-alone-in-us-participants-with-ea-62462https://curecurrent.com/trials/speech-language-treatment-with-remotely-supervised-transcranial-direct-current-stimulation-in-primary-progressive-aphasi-62463https://curecurrent.com/trials/brain-boosters-2-in-persons-at-risk-for-alzheimer-s-disease-a-digital-application-supported-intervention-62464https://curecurrent.com/trials/the-purpose-of-this-study-is-to-evaluate-the-safety-and-tolerability-of-x-t-x-ec-in-participants-with-alzheimer-s-diseas-62465https://curecurrent.com/trials/biomarkers-of-sleep-wake-cycle-in-prodromal-alzheimer-s-disease-role-in-cognitive-decline-62466https://curecurrent.com/trials/identification-of-diagnosis-biomarkers-in-the-tears-of-alzheimer-s-disease-patients-the-cog-eye-pilot-study-62467https://curecurrent.com/trials/optimizing-cognitive-environmental-and-neuromotor-stimulation-in-traumatic-brain-injury-62468https://curecurrent.com/trials/influence-of-age-on-amyloid-load-in-alzheimer-s-disease-and-in-atypical-focal-cortical-alzheimer-s-disease-62469https://curecurrent.com/trials/personalized-brain-stimulation-for-cognitive-impairment-in-older-adults-62470https://curecurrent.com/trials/intravenous-infusion-of-umbilical-cord-blood-as-an-adjunctive-treatment-for-alzheimer-s-disease-62471https://curecurrent.com/trials/brain-vascular-and-neurocognitive-health-62472https://curecurrent.com/trials/masitinib-in-patients-with-mild-alzheimer-s-disease-62473https://curecurrent.com/trials/diagnosis-and-monitoring-of-disease-progression-using-deep-neuro-signatures-62474https://curecurrent.com/trials/phase-3-double-blind-randomized-placebo-controlled-trial-to-evaluate-the-efficacy-and-safety-of-ar1001-in-participants-w-62475https://curecurrent.com/trials/integrating-metabolism-connectivity-and-mesoscale-imaging-at-ultra-high-field-to-decipher-mechanisms-of-resilience-and-n-62476https://curecurrent.com/trials/self-and-autobiographical-memory-in-dementia-with-lewy-bodies-and-alzheimer-disease-a-behavioral-and-multimodal-neuroima-62477https://curecurrent.com/trials/tspo-modulation-in-ad-62478https://curecurrent.com/trials/oral-semaglutide-in-patients-with-alzheimer-s-disease-62479https://curecurrent.com/trials/wecareadvisor-study-for-caregivers-of-people-living-with-dementia-62480https://curecurrent.com/trials/regenlife-rgn530-feasibility-pilot-62481https://curecurrent.com/trials/efficacy-of-gamification-in-enhancing-user-engagement-62482https://curecurrent.com/trials/development-of-a-novel-multidimensional-therapeutic-intervention-protocol-for-mci-62483https://curecurrent.com/trials/a-clinical-trial-to-determine-the-safety-and-efficacy-of-hope-biosciences-autologous-mesenchymal-stem-cell-therapy-hb-ad-62484https://curecurrent.com/trials/oct-angiography-and-adaptive-optics-in-patients-with-memory-impairment-62485https://curecurrent.com/trials/effectiveness-of-engaging-in-advance-care-planning-talks-enact-group-visits-in-primary-care-for-older-adults-with-and-wi-62486https://curecurrent.com/trials/anti-viral-therapy-in-alzheimer-s-disease-62487https://curecurrent.com/trials/development-of-an-eeg-diagnostic-for-alzheimer-s-disease-62488https://curecurrent.com/trials/tacad-program-for-asian-american-family-caregivers-of-persons-living-with-alzheimer-s-disease-62489https://curecurrent.com/trials/effects-of-personalized-music-listening-in-advanced-alzheimer-s-62490https://curecurrent.com/trials/nasal-protollin-in-early-symptomatic-alzheimer-s-disease-62491https://curecurrent.com/trials/prevention-of-anxiety-and-depression-over-risk-assessment-62492https://curecurrent.com/trials/simufilam-50-mg-or-100-mg-for-mild-to-moderate-alzheimer-s-disease-62493https://curecurrent.com/trials/the-sleep-amyloid-slow-wave-race-and-ethnicity-study-62494https://curecurrent.com/trials/nutrition-and-dementia-at-home-tomato-62495https://curecurrent.com/trials/the-predictplusprevent-study-62496https://curecurrent.com/trials/iona-longitudinal-cohort-study-62497https://curecurrent.com/trials/post-stroke-cognitive-impairment-and-dementia-62498https://curecurrent.com/trials/study-of-50561-in-patients-with-mild-or-moderate-alzheimer-s-disease-62499https://curecurrent.com/trials/in-home-technology-for-caregivers-of-people-with-dementia-and-mild-cognitive-impairment-spanish-language-homes-62500https://curecurrent.com/trials/in-home-technology-for-caregivers-of-people-with-dementia-and-mild-cognitive-impairment-wearables-62501https://curecurrent.com/trials/stress-and-hypertension-in-dementia-caregivers-62502https://curecurrent.com/trials/small-steps-towards-improving-activity-and-sleep-habits-to-decrease-the-risk-of-dementia-62503https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-neuroepo-in-subjects-with-mild-to-moderate-alzheimer-s-disease-62504https://curecurrent.com/trials/transcranial-pulse-stimulation-for-alzheimer-s-disease-62505https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-sage-718-in-participants-with-mild-cognitive-impairment-or-mild-demen-62506https://curecurrent.com/trials/pde5-inhibitor-for-alzheimer-s-disease-62507https://curecurrent.com/trials/transcranial-magnetic-stimulation-and-constraint-induced-language-therapy-for-alzheimer-disease-62508https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-sage-718-in-participants-with-mild-cognitive-impairment-or-mild-dementia-due-to-alzhe-62509https://curecurrent.com/trials/an-exploratory-study-of-near-infrared-light-therapy-for-mild-to-moderate-alzheimer-s-disease-62510https://curecurrent.com/trials/correlation-between-knowledge-attitude-and-practices-of-caregivers-and-oral-health-status-of-alzheimer-s-disease-patient-62511https://curecurrent.com/trials/oct-angiography-and-nrai-in-dementia-62512https://curecurrent.com/trials/new-biomarker-for-alzheimer-s-disease-diagnostic-62513https://curecurrent.com/trials/lithium-as-a-treatment-to-prevent-impairment-of-cognition-in-elders-62514https://curecurrent.com/trials/contribution-of-pathological-alpha-synuclein-as-a-diagnostic-biomarker-for-dementia-with-lewy-bodies-62515https://curecurrent.com/trials/the-effect-of-dual-task-training-on-cognitive-in-alzheimer-s-disease-62516https://curecurrent.com/trials/mind-diet-in-relation-to-malnutrition-and-depression-in-ad-62517https://curecurrent.com/trials/musical-engagement-of-brain-lobes-in-alzheimer-s-disease-patients-study-62518https://curecurrent.com/trials/near-infrared-light-therapy-combined-with-lecanemab-for-mild-alzheimer-s-disease-62519https://curecurrent.com/trials/effect-of-art-therapy-on-cognitive-and-hand-functions-of-alzheimer-s-patients-62520https://curecurrent.com/trials/music-listening-impact-on-quality-of-life-brain-and-burnout-of-alzheimer-patients-informal-caregivers-62521https://curecurrent.com/trials/18f-apn-1607-pet-in-subjects-with-ad-compared-to-hc-62522https://curecurrent.com/trials/cardiac-amyloid-deposits-and-heart-dysfunction-in-alzheimer-s-disease-62523https://curecurrent.com/trials/gv1001-subcutaneous-sc-for-the-treatment-of-mild-to-moderate-alzheimer-s-disease-ad-62524https://curecurrent.com/trials/safety-and-efficacy-of-trx0237-in-subjects-with-alzheimer-s-disease-followed-by-open-label-treatment-62525https://curecurrent.com/trials/therapeutic-efficacy-of-monoclonal-antibody-drugs-for-alzheimer-s-disease-based-on-pet-research-62526https://curecurrent.com/trials/synbiotic-formula-scv09-in-alzheimer-s-disease-patients-62527https://curecurrent.com/trials/prospective-cohort-study-of-patients-with-early-alzheimer-s-disease-treated-with-lecanemab-62528https://curecurrent.com/trials/the-care-ecosystem-consortium-effectiveness-study-62529https://curecurrent.com/trials/the-feasibility-safety-and-tolerability-of-vr-based-audiovisual-stimulation-62530https://curecurrent.com/trials/repurposing-bromocriptine-for-abeta-metabolism-in-alzheimer-s-disease-62531https://curecurrent.com/trials/using-srt-to-improve-the-drinking-problem-behavior-of-elderly-people-with-dementia-during-the-care-of-day-care-62532https://curecurrent.com/trials/a-phase-1-study-to-assess-the-safety-and-effects-of-single-and-multiple-doses-of-ks101-in-healthy-volunteers-62533https://curecurrent.com/trials/the-clinical-trial-of-low-dose-irradiation-for-alzheimer-s-disease-62534https://curecurrent.com/trials/environmental-pollutants-and-neurological-disorders-62535https://curecurrent.com/trials/improved-treatment-and-monitoring-of-alzheimer-s-disease-62536https://curecurrent.com/trials/digital-detection-of-dementia-d-cubed-studies-d2-62537https://curecurrent.com/trials/ectosomes-new-biomarkers-of-tau-pathology-62538https://curecurrent.com/trials/study-of-spg302-in-adult-participants-with-mild-to-moderate-alzheimer-s-disease-ad-62539https://curecurrent.com/trials/open-label-extension-of-the-pti-125-04-study-in-mild-to-moderate-alzheimer-s-disease-62540https://curecurrent.com/trials/digital-reminiscence-therapy-for-alzheimer-s-in-institutionalized-people-62541https://curecurrent.com/trials/predictive-factors-for-initial-mmse-score-and-rapid-decline-in-alzheimer-s-disease-patients-62542https://curecurrent.com/trials/the-remind-study-spark-neuro-software-study-62543https://curecurrent.com/trials/alzheimer-s-disease-multinuclear-imaging-neuro-enhanced-resolution-ad-miner-62544https://curecurrent.com/trials/proof-of-concept-study-of-new-imaging-diagnostic-in-patients-with-suspected-alzheimer-s-disease-62545https://curecurrent.com/trials/remote-sensing-for-adrd-specific-activities-identification-in-older-adults-62546https://curecurrent.com/trials/a-spanish-language-caregiver-enabled-care-program-62547https://curecurrent.com/trials/use-of-a-product-containing-the-cannabinoids-cbd-and-thc-as-a-treatment-strategy-for-alzheimer-s-disease-alzheimer-s-dis-62548https://curecurrent.com/trials/a-pet-and-tau-pet-imaging-in-the-diagnosis-and-progression-assessment-of-alzheimer-s-disease-62549https://curecurrent.com/trials/plans4care-personalized-dementia-care-on-demand-62550https://curecurrent.com/trials/comparison-of-two-modes-of-administration-of-the-iadl-questionnaire-assessing-the-level-of-functional-autonomy-of-patien-62551https://curecurrent.com/trials/biobank-and-brain-health-in-bordeaux-62552https://curecurrent.com/trials/analysis-of-18f-xtr006-pet-imaging-in-cognitively-normal-subjects-and-patients-with-mci-and-ad-62553https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ct1812-in-subjects-with-mild-to-moderate-alzheimer-s-disease-62554https://curecurrent.com/trials/smart-lighting-for-nursing-home-residents-with-dementia-62555https://curecurrent.com/trials/scgs-as-a-proxy-for-determining-the-cognitive-status-of-older-adults-62556https://curecurrent.com/trials/impact-of-a-biophoton-therapy-on-patients-with-brain-disorders-62557https://curecurrent.com/trials/communication-bridge-pilot-study-62558https://curecurrent.com/trials/imaging-biomarkers-in-preclinical-and-symptomatic-ad-62559https://curecurrent.com/trials/saliva-and-extracellular-vesicles-for-neurodegenerative-diseases-62560https://curecurrent.com/trials/biomarker-based-alzheimer-s-disease-cohort-study-basic-62561https://curecurrent.com/trials/effects-of-a-widely-used-vaccine-adjuvant-in-subjects-with-early-alzheimer-s-disease-double-blind-study-to-assess-the-sa-62562https://curecurrent.com/trials/radiolabeled-tspo-targeted-molecular-probe-in-alzheimer-s-disease-62563https://curecurrent.com/trials/atrial-amyloid-may-influence-outcomes-in-patients-undergoing-surgical-aortic-valve-replacement-62564https://curecurrent.com/trials/pilot-trial-evaluating-patient-experience-with-the-memorem-for-patients-with-neurological-diseases-62565https://curecurrent.com/trials/implementation-of-the-care-ecosystem-training-model-for-individuals-with-dementia-in-a-high-risk-integrated-care-managem-62566https://curecurrent.com/trials/implementation-of-function-focused-care-in-acute-care-62567https://curecurrent.com/trials/metabolic-characterization-of-alzheimer-s-disease-and-frontotemporal-dementia-by-23na-mri-and-fdg-pet-62568https://curecurrent.com/trials/self-administered-interactive-exercise-program-tele-exergame-62569https://curecurrent.com/trials/dementia-and-kidney-disease-epidemiological-approaches-to-risk-factors-and-treatment-strategies-62570https://curecurrent.com/trials/alzheimer-s-pet-imaging-in-racially-ethnically-diverse-adults-62571https://curecurrent.com/trials/negotiation-training-for-caregiver-communication-in-ad-62572https://curecurrent.com/trials/the-peripheral-blood-multi-omics-study-on-sleep-loss-62573https://curecurrent.com/trials/effectiveness-of-probiotic-k10-in-managing-health-outcomes-in-parkinson-and-alzheimer-disease-62574https://curecurrent.com/trials/cohort-study-on-cognitive-decline-in-elderly-62575https://curecurrent.com/trials/confidence-ai-financial-education-for-caregivers-confidence-ai-62576https://curecurrent.com/trials/study-safety-and-efficacy-of-deep-brain-stimulation-dbs-and-cervical-deep-lymphoid-venous-anastomosis-lva-in-alzheimer-s-62577https://curecurrent.com/trials/network-guided-tms-in-early-alzheimer-s-disease-62578https://curecurrent.com/trials/diagnostic-of-lewy-body-dementia-by-combining-scintigraphy-spect-using-a-specific-transporter-and-magnetic-resonance-ima-62579https://curecurrent.com/trials/visualizing-brain-proteinopathies-using-f-18-flornaptitril-pet-in-the-prediction-of-clinical-progression-of-mild-cogniti-62580https://curecurrent.com/trials/effect-of-a-modified-ketogenic-mediterranean-diet-on-alzheimer-s-disease-62581https://curecurrent.com/trials/biodistribution-of-11c-acetoacetate-18f-fluorodeoxyglucose-in-subjects-with-risk-factors-for-alzheimer-s-disease-62582https://curecurrent.com/trials/mindfulness-based-cognitive-coping-for-adrd-caregivers-62583https://curecurrent.com/trials/sniff-3-week-aptar-cps-device-62584https://curecurrent.com/trials/study-of-nasal-insulin-to-fight-forgetfulness-short-acting-insulin-aspart-62585https://curecurrent.com/trials/neurofilament-light-chains-and-cognitive-impairment-in-chronic-psychiatric-disease-62586https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-an-anti-mtbr-tau-monoclonal-antibody-bms-986446-in-participant-62587https://curecurrent.com/trials/acute-exercise-and-the-cerebral-metabolic-response-in-aging-and-alzheimer-s-disease-62588https://curecurrent.com/trials/the-clinical-study-of-synaptic-plasticity-based-lencanumab-for-the-treatment-of-early-alzheimer-s-disease-62589https://curecurrent.com/trials/apoe-in-the-predisposition-to-protection-from-and-prevention-of-alzheimer-s-disease-62590https://curecurrent.com/trials/a-multi-modal-combination-intervention-to-promote-cognitive-function-in-older-intensive-care-unit-survivors-62591https://curecurrent.com/trials/software-validation-study-cognitive-status-indicator-62592https://curecurrent.com/trials/a-phase-1-trial-to-assess-safety-tolerability-and-pharmacokinetics-of-alia-1758-in-healthy-participants-62593https://curecurrent.com/trials/rural-dementia-caregiver-project-62594https://curecurrent.com/trials/alzheimer-prevention-trials-apt-webstudy-62595https://curecurrent.com/trials/clinical-applicantion-of-multi-tracer-pet-mr-imaging-in-neurological-disorders-disease-62596https://curecurrent.com/trials/impact-of-musical-therapeutic-intervention-on-depression-in-dementia-patients-and-caregiver-burden-62597https://curecurrent.com/trials/understanding-brain-mechanisms-involved-in-autobiographical-memory-62598https://curecurrent.com/trials/motor-learning-in-health-and-movement-disorders-role-of-physical-activity-and-advanced-devices-62599https://curecurrent.com/trials/vr-based-multi-dimensional-intervention-on-cognitive-function-with-ai-agents-62600https://curecurrent.com/trials/a-prospective-multicenter-rct-study-of-deep-jugular-lymphovenous-anastomosis-in-the-treatment-of-alzheimer-s-disease-62601https://curecurrent.com/trials/a-trial-of-shr-1707-infusion-in-patients-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-and-mild-alzheimer-s-62602https://curecurrent.com/trials/daridorexant-to-prevent-delirium-after-heart-surgery-62603https://curecurrent.com/trials/a-study-of-ntrx-07-in-participants-with-alzheimer-s-disease-62604https://curecurrent.com/trials/yoga-based-movement-therapy-device-as-noninvasive-glymphatic-clearance-augmentation-in-alzheimer-s-disease-62605https://curecurrent.com/trials/deep-cervical-lymphatic-venous-anastomosis-in-the-treatment-of-alzheimer-s-disease-clean-ad-registry-62606https://curecurrent.com/trials/intergenerational-behavioral-intervention-to-enhance-physical-activity-in-older-adults-at-risk-for-alzheimer-s-disease-62607https://curecurrent.com/trials/sleep-stimulation-to-enhance-waste-clearance-in-the-brain-62608https://curecurrent.com/trials/white-matter-hyperintensities-in-amnestic-mild-cognitive-impairment-or-alzheimer-s-disease-62609https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-of-velusetrag-in-healthy-elderly-subjects-62610https://curecurrent.com/trials/huc-msc-sev-001-nasal-drops-for-neurodegenerative-diseases-62611https://curecurrent.com/trials/activity-of-cerebral-networks-amyloid-and-microglia-in-aging-and-alzheimer-s-disease-62612https://curecurrent.com/trials/amyloid-clearance-mechanisms-in-alzheimer-s-disease-62613https://curecurrent.com/trials/biomarkers-of-cognitive-impairment-in-blood-cells-62614https://curecurrent.com/trials/evaluating-rapamycin-treatment-in-alzheimer-s-disease-using-positron-emission-tomography-62615https://curecurrent.com/trials/mindfulness-to-reduce-loneliness-in-older-caregivers-62616https://curecurrent.com/trials/rexulti-drug-general-use-results-survey-excessive-motor-activity-or-physically-verbally-aggressive-behavior-due-to-rapid-62617https://curecurrent.com/trials/neuropsychological-evaluation-in-intellectual-disability-endi-62618https://curecurrent.com/trials/hypertension-intracranial-pulsatility-and-brain-amyloid-beta-accumulation-in-older-adults-hipac-trial-62619https://curecurrent.com/trials/screening-for-anti-amyloid-treatment-eligibility-using-digital-cognition-and-blood-based-biomarkers-62620https://curecurrent.com/trials/long-term-follow-up-of-gene-therapy-for-apoe4-homozygote-alzheimer-s-disease-62621https://curecurrent.com/trials/disclosing-dementia-risk-based-on-plasma-phosphorylated-tau-62622https://curecurrent.com/trials/e-tailored-pain-management-support-for-dementia-family-caregivers-feasibility-of-the-pace-app-62623https://curecurrent.com/trials/study-of-asn51-in-adults-with-early-alzheimer-s-disease-62624https://curecurrent.com/trials/7t-mri-for-light-therapy-in-patients-with-mild-cognitive-impairment-and-mild-ad-62625https://curecurrent.com/trials/old-school-hip-hop-parent-follow-up-spanish-speakers-inclusion-62626https://curecurrent.com/trials/sleep-impairment-in-subjects-at-risk-of-developing-alzheimer-s-disease-62627https://curecurrent.com/trials/lifestyle-for-the-brain-health-time-restricted-eating-and-mindfulness-62628https://curecurrent.com/trials/care-of-persons-with-dementia-in-their-environments-cope-in-programs-of-all-inclusive-care-of-the-elderly-pace-62629https://curecurrent.com/trials/evaluation-of-the-efficacy-of-an-app-for-parents-to-promote-healthy-life-styles-in-children-the-cosie-trial-62630https://curecurrent.com/trials/financial-incentives-and-recruitment-to-the-apt-webstudy-62631https://curecurrent.com/trials/validation-of-a-remediation-method-for-memory-disorders-using-motor-and-emotional-encoding-in-patients-with-alzheimer-s-62632https://curecurrent.com/trials/understanding-circadian-responses-to-light-in-persons-with-mild-cognitive-impairment-62633https://curecurrent.com/trials/12-month-real-world-safety-efficacy-of-lecanemab-in-early-alzheimer-s-disease-62634https://curecurrent.com/trials/the-comfortage-project-at-ace-alzheimer-center-barcelona-62635https://curecurrent.com/trials/impact-of-challenging-engagement-on-cognition-in-older-adults-62636https://curecurrent.com/trials/the-link-between-physical-activity-and-brain-health-in-healthy-adults-62637https://curecurrent.com/trials/yizhi-baduanjin-for-patients-with-cognitive-impairment-62638https://curecurrent.com/trials/effects-of-a-cognitive-engaging-strength-training-program-on-health-physical-condition-and-quality-of-life-in-people-wit-62639https://curecurrent.com/trials/a-follow-on-study-of-donanemab-ly3002813-with-video-assessments-in-participants-with-alzheimer-s-disease-trailblazer-ext-62640https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-gantenerumab-in-participants-at-risk-for-or-at-the-earliest-stages-of-alz-62641https://curecurrent.com/trials/exercise-workshop-skill-based-art-approaches-and-awareness-studies-for-elderly-individuals-62642https://curecurrent.com/trials/18f-av-1451-high-resolution-autopsy-study-62643https://curecurrent.com/trials/a-study-to-assess-safety-and-target-engagement-of-e2814-in-participants-with-mild-to-moderate-cognitive-impairment-due-t-62644https://curecurrent.com/trials/a-dyadic-approach-for-a-remote-physical-activity-intervention-in-adults-with-ad-and-their-caregivers-62645https://curecurrent.com/trials/alzheimer-s-disease-treated-with-vagus-nerve-stimulation-62646https://curecurrent.com/trials/time-restricted-eating-in-alzheimer-s-disease-62647https://curecurrent.com/trials/establishment-of-the-chinese-preclinical-alzheimer-s-disease-study-with-multiple-neuroimaging-62648https://curecurrent.com/trials/study-of-the-indications-for-amyloid-positon-emission-tomography-pet-scans-and-their-usefulness-for-patients-with-suspec-62649https://curecurrent.com/trials/biograph-vision-600-versus-biograph-vision-x-pet-ct-62650https://curecurrent.com/trials/atlas-of-retinal-imaging-in-alzheimer-s-study-62651https://curecurrent.com/trials/a-non-interventional-pilot-study-to-explore-the-role-of-gut-flora-in-alzheimer-s-disease-62652https://curecurrent.com/trials/feasibility-of-using-the-gatorade-sports-science-institute-gssi-labs-app-for-hydration-related-outcomes-62653https://curecurrent.com/trials/effect-of-exercise-endocannabinoids-and-ketones-on-cerebral-metabolism-in-a-cognitive-disorders-population-62654https://curecurrent.com/trials/rocky-mountain-alzheimer-s-disease-center-longitudinal-biomarker-and-clinical-phenotyping-study-62655https://curecurrent.com/trials/brain-energy-activation-with-ketones-to-prevent-alzheimer-s-disease-62656https://curecurrent.com/trials/advanced-alzheimer-disease-and-effects-of-protologic-and-language-rehabilitation-tools-in-nursing-home-adalpa-62657https://curecurrent.com/trials/longitudinal-study-for-the-characterization-of-the-phases-of-subjective-perception-of-cognitive-decline-and-mild-cogniti-62658https://curecurrent.com/trials/brain-characterization-of-amyloid-protein-and-glucose-metabolism-of-alfa-project-participants-62659https://curecurrent.com/trials/early-identification-of-markers-in-alzheimer-s-families-alfa-62660https://curecurrent.com/trials/alfasleep-exploring-cognitive-and-biological-correlates-of-sleep-quality-and-their-potential-links-with-alzheimer-s-dise-62661https://curecurrent.com/trials/aarc-cohort-study-for-the-identification-of-blood-based-biomarkers-in-a-population-with-subjective-cognitive-decline-62662https://curecurrent.com/trials/assessment-of-the-efficacy-safety-and-tolerability-of-avp-786-for-the-treatment-of-agitation-in-patients-with-dementia-o-62663https://curecurrent.com/trials/neurofilament-light-chain-and-voice-acoustic-analyses-in-dementia-diagnosis-62664https://curecurrent.com/trials/study-to-assess-the-efficacy-safety-and-tolerability-of-avp-786-for-the-treatment-of-agitation-in-patients-with-dementia-62665https://curecurrent.com/trials/a-study-assessing-the-safety-and-tolerability-of-ly03020-in-chinese-healthy-subjects-62666https://curecurrent.com/trials/german-validation-study-of-the-subjective-cognitive-decline-questionnaire-scd-q-62667https://curecurrent.com/trials/lifestyle-for-the-brain-health-nutrition-and-exercise-training-intervention-62668https://curecurrent.com/trials/deep-cervical-lymphaticovenous-anastomosis-surgery-for-moderate-to-advanced-dementia-patients-62669https://curecurrent.com/trials/effectiveness-of-a-3-month-individual-reminiscence-therapy-program-in-older-adults-with-alzheimer-s-disease-62670https://curecurrent.com/trials/home-based-brain-monitoring-with-a-garment-eeg-to-study-cognitive-decline-in-the-aging-population-62671https://curecurrent.com/trials/personalized-prevention-of-depression-in-primary-care-62672https://curecurrent.com/trials/swiss-postpartum-hypertension-cohort-62673https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-prosomnia-sleep-therapy-in-patients-with-sleep-deprivation-and-chronic-insomnia-62674https://curecurrent.com/trials/simufilam-100-mg-for-mild-to-moderate-alzheimer-s-disease-62675https://curecurrent.com/trials/use-of-a-cannabinoids-as-a-treatment-strategy-for-alzheimer-s-disease-62676https://curecurrent.com/trials/clinical-trial-of-agb101-for-mild-cognitive-impairment-62677https://curecurrent.com/trials/ultrasonic-neuromodulation-for-treatment-of-cognitive-impairment-62678https://curecurrent.com/trials/testing-the-efficacy-of-the-syd-app-on-improving-quality-of-life-and-mental-health-among-university-students-in-the-king-62679https://curecurrent.com/trials/open-label-extension-for-phase-3-clinical-trials-of-simufilam-62680https://curecurrent.com/trials/computerized-tests-of-cognitive-decline-in-presymptomatic-alzheimer-s-disease-62681https://curecurrent.com/trials/patient-centered-dementia-care-practice-coaching-intervention-62682https://curecurrent.com/trials/statins-in-reducing-events-in-the-elderly-mind-staree-mind-imaging-substudy-62683https://curecurrent.com/trials/transcranial-electromagnetic-treatment-against-alzheimer-s-disease-62684https://curecurrent.com/trials/vr-based-physical-activity-and-reminiscence-therapy-62685https://curecurrent.com/trials/clinical-evaluation-of-acupuncture-treatment-on-alzheimer-s-disease-in-apoe-e4-carriers-and-non-carriers-62686https://curecurrent.com/trials/co-design-and-pilot-study-in-vr-based-physical-activity-and-cognitive-training-62687https://curecurrent.com/trials/a-phase-1-mad-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ly03017-62688https://curecurrent.com/trials/evaluation-of-imaging-characteristics-of-18f-pi-2620-pet-in-ad-and-psp-patients-using-high-and-low-specific-activity-62689https://curecurrent.com/trials/mclena-2-a-phase-ii-clinical-trial-for-the-assessment-of-lenalidomide-in-patients-with-mild-cognitive-impairment-62690https://curecurrent.com/trials/the-effects-of-cognitive-behavioral-approach-based-psychoeducation-on-caregivers-of-alzheimer-s-patients-62691https://curecurrent.com/trials/health-kit-enabled-mobile-app-for-tobacco-cessation-62692https://curecurrent.com/trials/analyzing-the-benefits-of-using-symptoms-jit-for-in-vivo-exposure-in-anxiety-disorders-62693https://curecurrent.com/trials/a-pivotal-study-of-lipus-brain-in-patients-with-early-alzheimer-s-disease-62694https://curecurrent.com/trials/tms-as-a-treatment-for-apathy-in-alzheimer-s-disease-62695https://curecurrent.com/trials/the-prevention-trial-precision-recommendations-to-optimize-neurocognition-62696https://curecurrent.com/trials/a-relational-research-recruitment-and-engagement-intervention-for-cognitive-aging-research-62697https://curecurrent.com/trials/learning-and-coping-with-early-stage-dementia-62698https://curecurrent.com/trials/multiple-ascending-dose-safety-tolerability-pk-study-of-al001-in-alzheimer-s-disease-patients-healthy-adult-subjects-62699https://curecurrent.com/trials/greater-bay-area-healthy-aging-brain-study-ghabs-62700https://curecurrent.com/trials/lactate-for-energy-and-neurocognition-62701https://curecurrent.com/trials/novel-diagnostic-and-disease-stage-biomarkers-in-ad-62702https://curecurrent.com/trials/self-management-intervention-considering-needs-preferences-of-dementia-caregivers-caregiver-career-study-62703https://curecurrent.com/trials/effects-of-repetitive-transcranial-magnetic-stimulation-in-patients-with-alzheimer-s-disease-62704https://curecurrent.com/trials/safety-and-pharmacokinetics-of-single-ascending-doses-and-multiple-ascending-doses-of-cs6253-in-healthy-volunteers-62705https://curecurrent.com/trials/using-neuroimaging-to-early-diagnose-alzheimer-s-disease-through-hippocampal-atrophy-assessment-62706https://curecurrent.com/trials/application-of-ai-technology-for-the-diagnosis-and-treatment-of-geriatric-diseases-62707https://curecurrent.com/trials/validation-study-of-a-new-digital-diagnostic-and-treatment-test-based-on-interactive-video-games-for-alzheimer-s-disease-62708https://curecurrent.com/trials/a-phase-2b-3-clinical-study-evaluating-t3d-959-in-mild-to-moderate-alzheimer-s-disease-subjects-62709https://curecurrent.com/trials/trial-of-dronabinol-adjunctive-treatment-of-agitation-in-alzheimer-s-disease-62710https://curecurrent.com/trials/personalized-obstructive-sleep-apnea-treatment-and-effects-on-alzheimer-s-disease-biomarkers-and-cognition-among-blacks-62711https://curecurrent.com/trials/dynamic-light-scattering-ocular-measurement-in-the-detection-of-dementia-62712https://curecurrent.com/trials/imaging-tau-in-alzheimer-s-disease-and-normal-aging-62713https://curecurrent.com/trials/learning-and-improving-alzheimer-s-patient-caregiver-relationships-via-smart-healthcare-technology-62714https://curecurrent.com/trials/telmisartan-vs-perindopril-in-mild-moderate-alzheimer-s-disease-patients-62715https://curecurrent.com/trials/repurposing-nucleoside-reverse-transcriptase-inhibitors-for-treatment-of-ad-62716https://curecurrent.com/trials/the-effects-of-specific-tdcs-on-cognition-in-mci-62717https://curecurrent.com/trials/a-multiple-dose-trial-of-emraclidine-in-elderly-participants-and-in-participants-with-dementia-due-to-alzheimer-s-diseas-62718https://curecurrent.com/trials/caregiver-outcomes-of-alzheimer-s-disease-screening-62719https://curecurrent.com/trials/prediction-of-effectiveness-of-rtms-application-in-alzheimer-s-patients-62720https://curecurrent.com/trials/safety-pk-and-biodistribution-of-18f-op-801-in-patients-with-als-ad-ms-pd-and-healthy-volunteers-62721https://curecurrent.com/trials/medication-repurposing-to-stop-cognitive-decline-in-dementia-62722https://curecurrent.com/trials/statins-cholesterol-and-cognitive-decline-in-alzheimer-s-62723https://curecurrent.com/trials/obstructive-sleep-apnea-and-biomarkers-of-alzheimer-s-disease-62724https://curecurrent.com/trials/deep-brain-stimulation-of-the-pedunculopontine-nucleus-for-alzheimer-s-disease-62725https://curecurrent.com/trials/effects-of-brain-beta-amyloid-on-postoperative-cognition-62726https://curecurrent.com/trials/a-prospective-monocentric-clinical-study-for-the-validation-of-in-vitro-diagnostic-tests-developed-by-firalis-62727https://curecurrent.com/trials/early-onset-alzheimer-s-disease-phenotypes-neuropsychology-and-neural-networks-62728https://curecurrent.com/trials/effect-of-physiologic-insulin-administration-on-cognition-62729https://curecurrent.com/trials/a-dose-ranging-study-to-investigate-efficacy-of-buntanetap-in-mild-to-moderate-ad-62730https://curecurrent.com/trials/epigenetic-biomarkers-for-alzheimer-s-disease-62731https://curecurrent.com/trials/an-efficacy-and-safety-study-of-atabecestat-in-participants-who-are-asymptomatic-at-risk-for-developing-alzheimer-s-deme-62732https://curecurrent.com/trials/a-safety-and-tolerability-study-of-jnj-54861911-in-participants-with-early-alzheimer-s-disease-62733https://curecurrent.com/trials/an-extension-study-to-evaluate-the-long-term-safety-and-tolerability-of-jnj-54861911-in-participants-in-the-early-alzhei-62734https://curecurrent.com/trials/all-about-me-an-intervention-to-ease-the-transition-to-long-term-care-62735https://curecurrent.com/trials/a-study-of-seltorexant-in-participants-with-probable-alzheimer-s-disease-62736https://curecurrent.com/trials/histidine-oral-supplementation-as-a-therapeutic-modality-for-alzheimer-s-disease-62737https://curecurrent.com/trials/the-swedish-biofinder-study-62738https://curecurrent.com/trials/a-study-of-comparing-rates-of-dementia-and-alzheimer-s-disease-in-participants-initiating-methotrexate-versus-those-init-62739https://curecurrent.com/trials/a-study-to-investigate-safety-and-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-63733657-in-healthy-subjects-62740https://curecurrent.com/trials/characterization-of-t-cell-response-in-participants-previously-treated-with-jnj-54861911-atabecestat-62741https://curecurrent.com/trials/evaluation-of-tau-protein-in-the-brain-of-participants-with-alzheimer-s-disease-compared-to-healthy-participants-62742https://curecurrent.com/trials/multiple-dose-trial-of-mk-4334-in-participants-with-alzheimer-s-clinical-syndrome-mk-4334-005-62743https://curecurrent.com/trials/the-combined-aerobic-exercise-and-cognitive-training-act-trial-the-act-trial-62744https://curecurrent.com/trials/exploratory-clinical-study-to-assess-safety-and-efficacy-of-xenon-gas-inhalation-to-control-neuroinflammation-62745https://curecurrent.com/trials/cognitive-health-in-ageing-register-investigational-observational-and-trial-studies-in-dementia-research-prospective-rea-62746https://curecurrent.com/trials/assessing-the-effectiveness-of-an-approach-for-vocal-behaviors-in-older-people-living-in-nursing-homes-62747https://curecurrent.com/trials/scentaware-and-oct-in-mci-vs-hc-62748https://curecurrent.com/trials/a-study-to-verify-the-clinical-benefit-of-aducanumab-in-participants-with-early-alzheimer-s-disease-62749https://curecurrent.com/trials/asure-alzheimer-study-using-oral-edaravone-62750https://curecurrent.com/trials/the-reminder-program-for-older-adults-supported-by-residential-and-daycare-facilities-62751https://curecurrent.com/trials/simufilam-pti-125-100-mg-for-mild-to-moderate-alzheimer-s-disease-patients-62752https://curecurrent.com/trials/moving-together-an-online-group-movement-program-for-people-living-with-memory-loss-and-caregivers-62753https://curecurrent.com/trials/does-evoo-induce-gene-and-metabolic-changes-in-healthy-subjects-62754https://curecurrent.com/trials/hearing-aid-and-individuals-with-cognitive-disorders-62755https://curecurrent.com/trials/at-home-gamma-tacs-in-alzheimer-s-disease-tacs-home-62756https://curecurrent.com/trials/a-novel-therapeutic-target-for-alzheimer-s-disease-in-men-and-women-50-85-years-of-age-62757https://curecurrent.com/trials/first-in-human-evaluation-of-an-astrocytic-glutamate-transporter-eaat2-pet-tracer-in-dementia-62758https://curecurrent.com/trials/imaging-inflammation-in-alzheimer-s-disease-with-11c-er176-62759https://curecurrent.com/trials/salsalate-in-patients-mild-to-moderate-alzheimer-s-disease-62760https://curecurrent.com/trials/exploratory-evaluation-of-11c-mpc6827-62761https://curecurrent.com/trials/a-trial-to-evaluate-the-effects-of-bcg-in-adults-with-mci-and-mild-to-moderate-ad-62762https://curecurrent.com/trials/virtual-darkness-theraphy-for-agitation-in-dementia-62763https://curecurrent.com/trials/safety-and-target-engagement-of-centella-asiatica-in-cognitive-impairment-62764https://curecurrent.com/trials/optical-neuroimaging-and-cognition-62765https://curecurrent.com/trials/partners-at-meals-respite-care-and-home-pam-62766https://curecurrent.com/trials/clinical-study-on-lymphaticovenous-anastomosis-lva-for-the-treatment-of-alzheimer-s-disease-ad-62767https://curecurrent.com/trials/clinical-safety-and-efficacy-of-fecal-microbiota-transplantation-fmt-in-the-treatment-of-alzheimer-s-disease-62768https://curecurrent.com/trials/efficacy-of-hellencare-in-early-stage-alzheimer-s-disease-62769https://curecurrent.com/trials/finding-retinal-biomarkers-in-alzheimer-s-disease-62770https://curecurrent.com/trials/support-d-intervention-for-persons-with-alzheimer-s-disease-and-their-caregivers-62771https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ionis-maptrx-in-patients-with-mild-alzheimer-s-disease-62772https://curecurrent.com/trials/a-multidomain-intervention-program-for-older-people-with-dementia-62773https://curecurrent.com/trials/tau-pet-imaging-in-atypical-dementias-62774https://curecurrent.com/trials/ath-1017-for-treatment-of-mild-to-moderate-alzheimer-s-disease-62775https://curecurrent.com/trials/cultural-and-linguistic-adaptation-and-normative-study-of-the-turkish-version-of-the-free-and-cued-selective-reminding-t-62776https://curecurrent.com/trials/effects-of-app-assisted-home-exercise-program-in-patients-with-frozen-shoulder-62777https://curecurrent.com/trials/sleep-dependent-learning-in-aging-62778https://curecurrent.com/trials/cultural-adaptation-of-a-behavioral-intervention-for-latino-caregivers-62779https://curecurrent.com/trials/evaluation-of-the-structured-caregiver-support-program-scsp-in-terms-of-various-parameters-62780https://curecurrent.com/trials/strengthening-health-and-insight-in-new-educators-62781https://curecurrent.com/trials/effect-of-neuronavigated-theta-burst-transcranial-magnetic-stimulation-tbs-for-early-alzheimer-s-disease-62782https://curecurrent.com/trials/open-label-study-of-ath-1017-for-treatment-of-mild-to-moderate-alzheimer-s-disease-62783https://curecurrent.com/trials/adaptation-and-normalization-of-a-verbal-episodic-memory-test-in-french-sign-language-62784https://curecurrent.com/trials/detecting-early-alzheimer-s-using-mr-62785https://curecurrent.com/trials/distinguishing-between-alzheimer-s-disease-lewy-body-dementia-and-parkinson-s-disease-62786https://curecurrent.com/trials/resilient-together-for-dementia-62787https://curecurrent.com/trials/dmb-i-in-the-treatment-of-alzheimer-type-dementia-62788https://curecurrent.com/trials/quality-improvement-and-clinical-utility-precivityad2-tm-clinician-survey-62789https://curecurrent.com/trials/a-study-of-ly3372993-in-participants-with-alzheimer-s-disease-ad-and-healthy-participants-62790https://curecurrent.com/trials/gut-microbiome-and-blood-indices-in-patients-with-ad-and-their-spousal-caregivers-62791https://curecurrent.com/trials/diagnostic-evaluation-of-dementia-with-lewy-bodies-using-a-multimodal-approach-62792https://curecurrent.com/trials/a-mobile-informatics-solution-to-aid-in-memory-62793https://curecurrent.com/trials/a-pilot-study-on-app-based-treatment-combining-physical-exercise-graded-activity-and-pain-journaling-for-patients-with-s-62794https://curecurrent.com/trials/understanding-cerebral-blood-flow-dynamics-for-alzheimer-s-disease-prevention-through-exercise-62795https://curecurrent.com/trials/amper-proof-of-concept-study-62796https://curecurrent.com/trials/epileptic-activity-in-patients-with-alzheimer-s-disease-and-lewy-body-dementia-62797https://curecurrent.com/trials/clinical-evaluation-of-blood-based-assays-for-rapid-detection-of-a-pathology-in-alzheimer-s-disease-62798https://curecurrent.com/trials/safe-at-home-a-service-to-provide-social-engagement-to-community-dwelling-persons-with-dementia-62799https://curecurrent.com/trials/autopsy-follow-up-of-subjects-previously-imaged-with-florbetapir-f-18-18f-av-45-pet-in-trial-18f-av-45-a07-62800https://curecurrent.com/trials/korean-joint-registry-for-alzheimer-s-treatment-and-diagnostics-joy-alz-62801https://curecurrent.com/trials/living-well-with-chronic-pain-62802https://curecurrent.com/trials/nalysis-of-the-periodontal-microbiota-in-elderly-subjects-with-and-without-alzheimer-s-disease-a-case-control-study-62803https://curecurrent.com/trials/stress-management-intervention-in-early-stage-cancer-randomized-controlled-trial-62804https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-bey2153-in-patients-with-early-alzheimer-s-disease-62805https://curecurrent.com/trials/a-study-of-cm383-in-patients-with-alzheimer-s-disease-related-mild-cognitive-impairment-and-mild-alzheimer-s-disease-62806https://curecurrent.com/trials/neuropsychological-profiles-and-musical-engagement-in-parkinson-s-and-alzheimer-s-disease-62807https://curecurrent.com/trials/lecanemab-for-early-onset-familial-alzheimer-s-disease-62808https://curecurrent.com/trials/novel-neuroradiological-workflow-for-the-assisted-diagnosis-and-management-of-dementia-with-artificial-intelligence-62809https://curecurrent.com/trials/association-between-age-related-macular-degeneration-and-cognitive-impairment-based-on-exosome-proteomics-62810https://curecurrent.com/trials/discovery-and-validation-of-protein-structural-complexes-in-circulating-biofluids-as-novel-biomarkers-for-early-diagnosi-62811https://curecurrent.com/trials/does-bcg-vaccination-reduce-biomarkers-of-alzheimer-s-disease-62812https://curecurrent.com/trials/effect-of-probiotics-in-alzheimer-s-disease-62813https://curecurrent.com/trials/reducing-african-american-s-alzheimer-s-risk-through-exercise-mild-cognitive-impairment-raate-mci-62814https://curecurrent.com/trials/safety-and-feasibility-of-dasatinib-and-quercetin-in-adults-at-risk-for-alzheimer-s-disease-62815https://curecurrent.com/trials/brain-connectivity-marker-for-alzheimer-s-disease-62816https://curecurrent.com/trials/university-of-central-florida-cerebank-62817https://curecurrent.com/trials/an-innovative-platform-for-objective-monitoring-of-instrumental-activities-of-daily-living-62818https://curecurrent.com/trials/an-innovative-method-in-saliva-samples-for-the-early-differential-diagnosis-of-high-impact-neurodegenerative-diseases-th-62819https://curecurrent.com/trials/pilot-mobile-for-dementia-and-frailty-62820https://curecurrent.com/trials/study-to-detect-dendritic-cell-recruitment-in-human-retina-62821https://curecurrent.com/trials/an-exploratory-study-to-confirm-efficacy-of-modified-deep-cervical-lymphovenous-anastomosis-lva-in-alzheimer-s-disease-p-62822https://curecurrent.com/trials/holistic-nursing-benefits-cognitive-and-psychiatric-symptoms-in-alzheimer-s-patients-62823https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-and-safety-of-bey2153-in-healthy-participants-62824https://curecurrent.com/trials/efficacy-and-safety-of-conventional-symptomatic-drugs-combined-with-lencanizumab-in-the-treatment-of-early-alzheimer-s-d-62825https://curecurrent.com/trials/motivating-change-in-aging-smokers-62826https://curecurrent.com/trials/mindspeed-food-and-brain-training-rct-62827https://curecurrent.com/trials/study-to-assess-the-safety-and-biological-activity-of-amx0035-for-the-treatment-of-alzheimer-s-disease-62828https://curecurrent.com/trials/brain-functional-changes-accompany-modulatory-effects-of-transcranial-direct-current-stimulation-in-cognitive-impairment-62829https://curecurrent.com/trials/life-dsr-biomarker-sub-study-of-biomarkers-in-down-syndrome-related-alzheimer-s-disease-ds-ad-62830https://curecurrent.com/trials/acrylamide-and-health-outcomes-62831https://curecurrent.com/trials/efficacy-study-of-kinto-care-coaching-for-dementia-family-caregivers-62832https://curecurrent.com/trials/imaging-inflammation-in-alzheimer-s-disease-62833https://curecurrent.com/trials/noninvasive-brain-stimulation-in-mild-cognitive-impairment-and-dementia-62834https://curecurrent.com/trials/development-of-ips-from-donated-somatic-cells-of-patients-with-neurological-diseases-62835https://curecurrent.com/trials/investigating-genetic-status-in-patients-presenting-to-clinic-62836https://curecurrent.com/trials/genetic-studies-in-familial-dementia-62837https://curecurrent.com/trials/biomarkers-for-monitoring-dementia-progression-62838https://curecurrent.com/trials/designing-a-tailored-primary-care-intervention-to-manage-the-burden-of-caring-for-patients-living-with-alzheimer-s-disea-62839https://curecurrent.com/trials/music-memory-a-pragmatic-trial-for-nursing-home-residents-with-alzheimer-s-disease-metrical-part2-62840https://curecurrent.com/trials/plasma-p-tau2017-and-quantitative-amyloid-pet-imaging-62841https://curecurrent.com/trials/efficacy-and-safety-of-dimethyl-fumarate-among-patients-with-mild-cognitive-impairment-and-dementia-due-to-alzheimer-s-d-62842https://curecurrent.com/trials/a-study-of-oral-ex039-in-subjects-with-mild-alzheimer-s-disease-62843https://curecurrent.com/trials/caregiver-speaks-a-technologically-mediated-storytelling-intervention-62844https://curecurrent.com/trials/in-home-technology-for-caregivers-of-people-with-dementia-and-mild-cognitive-impairment-rural-homes-62845https://curecurrent.com/trials/biomarkers-in-a-candian-memory-clinic-62846https://curecurrent.com/trials/fundus-camera-module-for-early-detection-of-alzheimer-s-disease-62847https://curecurrent.com/trials/a-study-to-evaluate-safety-and-tolerability-of-aducanumab-in-participants-with-alzheimer-s-disease-who-had-previously-pa-62848https://curecurrent.com/trials/the-safety-and-efficacy-of-sodium-pentaborate-pentahydrate-in-patients-with-mild-to-moderate-alzheimer-s-disease-62849https://curecurrent.com/trials/a-longitudinal-study-to-explore-the-impact-of-gut-microbiome-on-brain-health-in-alzheimer-s-disease-62850https://curecurrent.com/trials/quality-improvement-precivityad-clinician-survey-quip-i-62851https://curecurrent.com/trials/rivastigmine-mini-tablet-for-alzheimer-s-disease-62852https://curecurrent.com/trials/detecting-an-mci-and-amyloid-digital-neuro-signature-dns-using-altoida-s-multimodal-digital-biomarkers-62853https://curecurrent.com/trials/teambaby-safe-digitally-supported-communication-in-obstetrics-and-gynecology-62854https://curecurrent.com/trials/18f-av45-a-and-18f-av1451-tau-pet-ct-in-the-diagnosis-of-early-pathological-changes-of-alzheimer-s-disease-62855https://curecurrent.com/trials/tetra-picasso-ad-trial-study-to-evaluate-effects-of-bpn14770-in-early-alzheimer-s-subjects-62856https://curecurrent.com/trials/11c-pib-pet-study-in-mesa-at-columbia-university-62857https://curecurrent.com/trials/long-term-follow-up-of-cognitive-and-functional-evolutions-of-persons-with-isolated-cognitive-complaints-or-mild-cogniti-62858https://curecurrent.com/trials/the-role-of-advanced-electroencephalographic-data-as-marker-of-pathology-and-prognosis-in-primary-dementias-62859https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-immunogenicity-of-tau-targeted-vaccines-in-participants-with-early-alzhe-62860https://curecurrent.com/trials/a-practical-platform-for-in-home-remote-monitoring-of-cognitive-frailty-62861https://curecurrent.com/trials/pilot-pragmatic-clinical-trial-to-embed-tele-savvy-into-health-care-systems-62862https://curecurrent.com/trials/nursing-interventions-for-alzheimer-s-patients-during-pet-ct-imaging-62863https://curecurrent.com/trials/digital-twins-for-model-driven-non-invasive-electrical-brain-stimulation-62864https://curecurrent.com/trials/marker-of-brain-insulin-resistance-in-ad-prognosis-62865https://curecurrent.com/trials/uppsala-dalarna-dementia-and-gait-project-62866https://curecurrent.com/trials/telehealth-enabled-integrated-palliative-care-for-people-with-dementia-62867https://curecurrent.com/trials/probiotics-in-dementia-62868https://curecurrent.com/trials/home-test-for-measuring-plasma-p-tau217-in-alzheimer-s-disease-62869https://curecurrent.com/trials/assessing-a-novel-virtual-environment-that-assists-with-activities-of-daily-living-62870https://curecurrent.com/trials/monitoring-anti-dementia-drugs-by-serum-levels-62871https://curecurrent.com/trials/a-phase-1-study-of-vg-3927-in-healthy-adults-and-patients-with-alzheimer-s-disease-62872https://curecurrent.com/trials/a-study-evaluating-the-potential-of-bms-984923-to-alter-the-systemic-exposure-of-three-orally-administered-probe-substra-62873https://curecurrent.com/trials/18f-mfbg-versus-123i-mibg-and-18f-pe2i-in-pd-vs-msa-and-dlb-vs-ad-62874https://curecurrent.com/trials/reminder-a-digital-environmental-enrichment-intervention-62875https://curecurrent.com/trials/identification-of-patients-with-a-high-probability-of-meeting-eligibility-criteria-for-an-alzheimer-s-disease-clinical-t-62876https://curecurrent.com/trials/star-caregivers-virtual-training-and-follow-up-62877https://curecurrent.com/trials/dominantly-inherited-alzheimer-network-trial-an-opportunity-to-prevent-dementia-a-study-of-potential-disease-modifying-t-62878https://curecurrent.com/trials/a-phase-ii-study-to-assess-the-safety-tolerability-and-efficacy-of-xanamem-in-subjects-with-mild-dementia-due-to-ad-xana-62879https://curecurrent.com/trials/long-term-safety-of-tafamidis-in-subjects-with-transthyretin-cardiomyopathy-62880https://curecurrent.com/trials/escitalopram-for-agitation-in-alzheimer-s-disease-62881https://curecurrent.com/trials/pre-pilot-problem-adaptation-therapy-in-caregivers-62882https://curecurrent.com/trials/a-study-on-the-safety-tolerability-and-immunogenicity-of-alz-101-in-participants-with-early-alzheimer-s-disease-62883https://curecurrent.com/trials/d-care-the-dementia-care-study-a-pragmatic-clinical-trial-of-health-system-based-versus-community-based-dementia-care-62884https://curecurrent.com/trials/proof-of-concept-open-label-study-in-patients-with-early-alzheimer-s-disease-62885https://curecurrent.com/trials/investigating-brain-insulin-resistance-in-alzheimer-disease-with-intranasal-insulin-a-multimodal-neuroimaging-study-62886https://curecurrent.com/trials/hormone-replacement-trial-against-alzheimers-disease-62887https://curecurrent.com/trials/mindfulness-for-cognition-in-early-stage-alzheimer-s-disease-62888https://curecurrent.com/trials/effect-of-food-and-age-on-the-pharmacokinetics-of-ly03017-62889https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-long-term-safety-sodium-oligomannate-capsules-gv-971-62890https://curecurrent.com/trials/assessing-the-impact-of-day-programs-on-individuals-living-with-dementia-and-their-family-friend-caregivers-62891https://curecurrent.com/trials/exploring-patterns-of-use-and-effects-of-adult-day-programs-to-improve-trajectories-of-continuing-care-62892https://curecurrent.com/trials/a-study-of-cst-2032-and-cst-107-in-subjects-with-mild-cognitive-impairment-or-mild-dementia-due-to-parkinson-s-or-alzhei-62893https://curecurrent.com/trials/dynamic-response-to-probiotics-in-context-of-alzheimer-disease-a-proof-of-concept-study-62894https://curecurrent.com/trials/a-double-blind-placebo-controlled-dose-ranging-study-of-xanamem-in-healthy-elderly-volunteers-62895https://curecurrent.com/trials/a-phase-3-study-of-rotigotine-in-combination-with-rivastigmine-in-mild-to-moderate-alzheimer-s-disease-62896https://curecurrent.com/trials/clinical-safety-and-efficacy-evaluation-of-nanolithium-np03-in-patients-with-mild-to-severe-alzheimer-s-disease-62897https://curecurrent.com/trials/evaluation-of-the-effects-of-serious-cognitive-games-on-a-digital-tactile-table-for-elderly-people-with-alzheimer-s-dise-62898https://curecurrent.com/trials/targeting-default-mode-network-dysfunction-in-persons-at-risk-of-alzheimer-s-disease-with-non-invasive-techniques-62899https://curecurrent.com/trials/deep-cervical-lymphatlc-venous-anastomosis-surgery-for-the-treatment-of-alzheimer-s-disease-a-pilot-study-diva-study-62900https://curecurrent.com/trials/a-diagnostic-test-for-dementia-with-lewy-bodies-62901https://curecurrent.com/trials/cpap-randomized-controlled-trial-62902https://curecurrent.com/trials/localized-analysis-of-normalized-distance-from-scalp-to-cortex-and-personalized-evaluation-landscape-62903https://curecurrent.com/trials/combined-artificial-intelligence-and-mobile-application-for-remote-infant-motor-screening-development-and-validation-62904https://curecurrent.com/trials/a-study-of-silkworm-pupa-powder-intervention-in-the-nutritional-status-of-patients-with-alzheimer-s-disease-62905https://curecurrent.com/trials/tablet-based-cognitive-training-62906https://curecurrent.com/trials/speeko-for-elderspeak-a-self-monitoring-app-to-improve-nursing-home-communication-62907https://curecurrent.com/trials/cognition-age-and-rapamycin-effectiveness-downregulation-of-the-mtor-pathway-62908https://curecurrent.com/trials/bnh-015b-clinical-trial-in-moderate-alzheimer-s-disease-62909https://curecurrent.com/trials/monitoring-drug-efficacy-in-patients-with-alzheimer-s-disease-62910https://curecurrent.com/trials/transmagnetic-stimulation-pilot-in-early-stage-alzheimer-s-disease-62911https://curecurrent.com/trials/effects-of-3-month-melatonin-treatment-on-regional-cerebellar-structure-and-blood-biomarkers-in-alzheimer-s-disease-spec-62912https://curecurrent.com/trials/psychological-counseling-program-for-alzheimer-s-patients-caregivers-62913https://curecurrent.com/trials/blood-biomarkers-from-internal-jugular-vein-for-the-diagnosis-of-alzheimer-s-disease-62914https://curecurrent.com/trials/virtual-reality-cognitive-therapy-for-alzheimer-s-disease-62915https://curecurrent.com/trials/palliative-care-for-persons-with-adrd-and-ci-in-snf-62916https://curecurrent.com/trials/paediatric-peri-operative-anxiety-does-the-little-journey-app-help-62917https://curecurrent.com/trials/cohort-of-patients-with-alzheimer-s-disease-and-their-families-62918https://curecurrent.com/trials/a-clinical-trial-to-access-pharmacokinetic-profiles-and-safety-of-ivl3003-62919https://curecurrent.com/trials/tdcs-and-cognitive-efficiency-in-ageing-62920https://curecurrent.com/trials/families-coping-together-with-alzheimer-s-disease-62921https://curecurrent.com/trials/social-cognition-and-personality-changes-in-alzheimer-s-parkinson-s-disease-frontotemporal-lobar-degeneration-62922https://curecurrent.com/trials/long-term-effect-of-tms-in-primary-progressive-aphasia-62923https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-itraconazole-on-mk-1708-in-healthy-participants-mk-1708-003-62924https://curecurrent.com/trials/interest-of-the-reborn-doll-as-a-to-in-the-care-of-residents-with-alzheimer-s-disease-or-a-related-disorder-62925https://curecurrent.com/trials/biofinder-brown-examination-of-alzheimer-s-disease-biomarkers-62926https://curecurrent.com/trials/transcranial-pulse-stimulation-a-potential-treatment-for-early-dementia-62927https://curecurrent.com/trials/working-memory-training-in-patients-with-mild-cognitive-impairment-62928https://curecurrent.com/trials/amyloid-and-glucose-pet-imaging-in-alzheimer-and-vascular-cognitive-impairment-patients-with-significant-white-matter-di-62929https://curecurrent.com/trials/proteinopathies-expression-in-skin-of-neurodegenerative-disorders-62930https://curecurrent.com/trials/nature-based-virtual-reality-intervention-for-depression-in-alzheimer-s-disease-62931https://curecurrent.com/trials/c-11-pib-pet-imaging-in-alcohol-use-disorders-62932https://curecurrent.com/trials/association-of-transcranial-alternating-current-stimulation-with-digital-cognitive-training-for-cognitive-remediation-in-62933https://curecurrent.com/trials/mad-study-of-nx210c-62934https://curecurrent.com/trials/molecular-pet-imaging-and-plasma-biomarkers-in-alzheimer-s-disease-and-other-neurodegenerative-diseases-62935https://curecurrent.com/trials/multicultural-healthy-diet-to-reduce-cognitive-decline-62936https://curecurrent.com/trials/coach-cog-intervention-adaptation-focus-groups-62937https://curecurrent.com/trials/we-pap-a-couples-based-intervention-for-sleep-apnea-62938https://curecurrent.com/trials/efficacy-and-safety-of-mk-1942-as-an-adjunct-therapy-in-participants-with-mild-to-moderate-alzheimer-s-disease-dementia-62939https://curecurrent.com/trials/utilization-of-exergame-programs-among-elderly-residents-in-rural-nursing-care-centers-62940https://curecurrent.com/trials/new-imaging-biomarkers-predictive-of-ma-progression-62941https://curecurrent.com/trials/dementia-risk-prediction-model-development-and-validation-62942https://curecurrent.com/trials/the-impact-of-art-therapy-on-the-relationships-between-individuals-diagnosed-with-alzheimer-s-disease-and-their-care-par-62943https://curecurrent.com/trials/implications-for-management-of-pet-amyloid-classification-technology-in-the-imaging-dementia-ideas-trial-62944https://curecurrent.com/trials/sequential-dose-escalation-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-tb006-in-healthy-subjects-62945https://curecurrent.com/trials/design-of-personalised-supplements-based-on-the-gut-microbiota-through-artificial-intelligence-for-alzheimer-s-patients-62946https://curecurrent.com/trials/tb006-expanded-access-ea-compassionate-use-62947https://curecurrent.com/trials/delivery-format-of-cognitive-behavioral-therapy-materials-on-engagement-and-outcomes-ai-enabled-app-vs-pdf-workbook-62948https://curecurrent.com/trials/probiotics-in-mild-alzheimer-s-disease-62949https://curecurrent.com/trials/app-based-consent-for-pediatric-clinical-research-62950https://curecurrent.com/trials/prevalence-of-alzheimer-s-disease-pathology-in-the-community-62951https://curecurrent.com/trials/personalized-nutrition-and-ehealth-lifestyle-intervention-lion-study-for-weight-loss-maintenance-62952https://curecurrent.com/trials/efficacy-and-safety-of-wei-li-bai-capsules-in-the-treatment-of-alzheimer-s-disease-62953https://curecurrent.com/trials/effects-of-endogenous-gamma-light-stimulation-on-brain-oscillations-in-cognitively-normal-older-adults-62954https://curecurrent.com/trials/determination-of-walking-balance-fall-risk-and-kinesiophobia-in-individulas-with-alzheimer-s-dementation-62955https://curecurrent.com/trials/virtual-reality-intervention-for-the-reduction-of-behavioral-and-psychological-symptoms-of-dementia-62956https://curecurrent.com/trials/lead-it-an-app-to-enable-persons-with-early-stage-dementia-to-lead-group-activities-for-their-peers-62957https://curecurrent.com/trials/pilot-clinical-study-of-ct1812-in-mild-to-moderate-alzheimer-s-disease-using-eeg-62958https://curecurrent.com/trials/a-study-of-donanemab-ly3002813-compared-with-aducanumab-in-participants-with-early-symptomatic-alzheimer-s-disease-trail-62959https://curecurrent.com/trials/a-program-to-reduce-inappropriate-medications-among-older-adults-with-alzheimer-s-disease-62960https://curecurrent.com/trials/exploration-of-the-efficacy-and-mechanisms-of-lymphaticovenous-anastomosis-in-the-treatment-of-alzheimer-s-disease-62961https://curecurrent.com/trials/brain-amyloid-and-vascular-effects-of-eicosapentaenoic-acid-62962https://curecurrent.com/trials/ruijin-neurobank-of-alzheimer-s-disease-and-dementia-62963https://curecurrent.com/trials/reducing-african-americans-alzheimer-s-disease-risk-through-exercise-raate-62964https://curecurrent.com/trials/shanghai-non-pharmacological-intervention-for-mild-cognitive-impairment-and-mild-alzheimer-s-disease-62965https://curecurrent.com/trials/alzheimer-s-disease-neuroimaging-initiative-2-62966https://curecurrent.com/trials/clinical-application-and-usability-of-blood-biomarkers-as-screening-tool-in-alzheimer-disease-a-validation-study-62967https://curecurrent.com/trials/assessment-of-the-efficacy-safety-and-tolerability-of-avp-786-deudextromethorphan-hydrobromide-d6-dm-quinidine-sulfate-q-62968https://curecurrent.com/trials/the-study-of-nasal-insulin-in-the-fight-against-forgetfulness-sniff-62969https://curecurrent.com/trials/an-observational-study-of-patients-living-with-chronic-neurological-diseases-62970https://curecurrent.com/trials/efficacy-safety-of-astragalus-membranaceus-in-mild-to-moderate-alzheimer-s-disease-62971https://curecurrent.com/trials/long-term-efficacy-and-safety-study-of-gv-971-62972https://curecurrent.com/trials/brexpiprazole-for-the-treatment-of-patients-with-agitation-associated-with-dementia-of-the-alzheimer-s-type-62973https://curecurrent.com/trials/lacunar-intervention-laci-2-trial-2-62974https://curecurrent.com/trials/efficacy-and-safety-of-flos-gossypii-flavonoids-tablet-in-the-treatment-of-alzheimer-s-disease-62975https://curecurrent.com/trials/gamification-in-the-treatment-of-spider-phobia-62976https://curecurrent.com/trials/single-dose-escalation-study-of-cm383-in-healthy-volunteers-62977https://curecurrent.com/trials/study-on-aging-and-cognitive-impairment-in-china-62978https://curecurrent.com/trials/targeting-zdhhc-enzymes-to-counteract-alzheimer-s-disease-62979https://curecurrent.com/trials/voice-and-swallowing-disorders-in-adults-with-and-without-alzheimer-s-disease-62980https://curecurrent.com/trials/advance-ii-study-dbs-f-in-patients-with-mild-alzheimer-s-disease-62981https://curecurrent.com/trials/effects-of-visual-cues-and-education-for-people-who-live-within-long-term-care-communities-to-assist-in-wayfinding-62982https://curecurrent.com/trials/the-retain-your-brain-health-study-retainyourbrain-com-62983https://curecurrent.com/trials/itbs-in-mci-and-mild-ad-62984https://curecurrent.com/trials/a-study-of-the-effects-of-cy6463-in-participants-with-alzheimer-s-disease-with-vascular-pathology-62985https://curecurrent.com/trials/a-study-of-the-safety-and-tolerability-of-asp0777-in-subjects-with-alzheimer-s-disease-ad-taking-a-stable-dose-of-donepe-62986https://curecurrent.com/trials/cognition-platform-study-in-participants-at-risk-for-alzheimer-s-disease-ad-mk-0000-413-62987https://curecurrent.com/trials/a-study-comparing-the-safety-tolerability-and-pharmacokinetics-of-sabirnetug-iv-and-sabirnetug-rhuph20-sc-in-healthy-par-62988https://curecurrent.com/trials/repetitive-tms-of-the-posterior-dmn-in-ad-62989https://curecurrent.com/trials/communication-bridge-2-62990https://curecurrent.com/trials/clinical-evaluation-of-florbetapir-in-primary-progressive-aphasia-62991https://curecurrent.com/trials/florbetaben-pet-imaging-in-ppa-62992https://curecurrent.com/trials/cb3-pilot-communication-bridge-a-person-centered-internet-based-intervention-for-individuals-with-primary-progressive-ap-62993https://curecurrent.com/trials/recognizing-pain-intensity-in-alzheimer-s-disease-62994https://curecurrent.com/trials/combined-effect-of-tdcs-and-motor-or-cognitive-activity-in-patients-with-alzheimer-s-disease-62995https://curecurrent.com/trials/constellations-living-lab-improving-the-care-transitions-of-older-adults-living-with-neurocognitive-disorders-62996https://curecurrent.com/trials/recoveryfun-an-integrated-vr-based-tele-rehabilitation-platform-to-support-recovery-and-maintenance-of-functional-abilit-62997https://curecurrent.com/trials/phase-2-study-to-examine-grape-seed-extract-as-an-anti-oligomerization-agent-in-alzheimer-s-disease-ad-62998https://curecurrent.com/trials/cerebellar-itbs-mode-transcranial-magnetic-stimulation-for-the-treatment-of-alzheimer-s-disease-62999https://curecurrent.com/trials/hp-xenon-129-fmri-of-healthy-volunteers-and-participants-with-alzheimer-s-disease-63000https://curecurrent.com/trials/ai-app-for-management-of-atopic-dermatitis-63001